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Thyroid hormone synthesis requires secretion of thyroglobulin, a precursor 
protein comprising Cys-rich regions I, II, and III (referred to collectively as regions I-II-
III) followed by a cholinesterase-like (ChEL) domain. Secretion of mature thyroglobulin 
requires extensive folding and oligomerization in the ER. Multiple reports have linked 
mutations in the ChEL domain to thyroid diseases in humans and other animals; these 
mutations block thyroglobulin from exiting the ER and induce ER stress. The principal 
hypothesis in this thesis is that thyroglobulin requires the ChEL domain to form its native 
tertiary and quaternary structure. We report that, in a cell culture system, thyroglobulin 
with misfolding mutations in the ChEL domain also impairs folding in other domains. A 
truncated thyroglobulin (regions I-II-III) devoid of the ChEL domain is incompetent for 
folding and cellular export. However, co-expression of a secretory ChEL domain (which 
is efficiently secreted) with the truncated thyroglobulin rescued secretion of regions I-II-
III by promoting their oxidative maturation and folding. The data indicate that the ChEL 
domain functions as an intramolecular chaperone. Moreover, a functional ChEL domain 
engineered to be retained intracellularly co-retains truncated thyroglobulin even as it 
facilitates the oxidative maturation of regions I-II-III. This indicates that the ChEL 
domain is also employed as a molecular escort for thyroglobulin. Thyroglobulin becomes 
a homodimer within the endoplasmic reticulum. The ChEL domain sequence contains 
predicted helical structures that are homologous to the dimerization helices of 
acetylcholinesterase. I have found that the ChEL domain can dimerize with itself, just as 
acetylcholinesterase does, and this is likely to drive the dimerization of wild-type 
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thyroglobulin. Insertion of an N-linked glycan into one of the putative dimerization 
helices blocks detectable homodimerization of the isolated ChEL domain. Interestingly, 
co-expression of upstream regions of thyroglobulin, I-II-III, either in cis or in trans, 
overrides the dimerization defect of such a mutant. These data suggest that intermonomer 
interactions of the ChEL domain of thyroglobulin are enhanced by additional interactions 
with upstream regions of thyroglobulin. I conclude that the ChEL domain is required to 
form a native structure of Tg which is essential for export from the endoplasmic 
reticulum, and for thyroid hormone formation. This role is fulfilled by functioning as an 







Overview of thyroid hormone biosynthesis 
Thyroid hormone regulates a broad range of physiological responses engaged in 
growth, development, and metabolism [1]. The thyroid hormone is synthesized from a 
matrix protein, thyroglobulin (Tg). Tg is the most abundant protein in the thyroid gland. 
Tg is a large homodimeric protein with a molecular weight of 330 kDa per monomer, 
while the thyroid hormone thyroxine is a small molecule composed of only two di-
iodinated tyrosines derived from Tg.
Thyroid hormonogenesis engages a biosynthetic pathway that ultimately 
encompasses multiple organ systems. Tg gene expression occurs in thyrocytes of the 
thyroid gland (which resides in the lower part of the neck) and is positively regulated by 
thyroid stimulating hormone (TSH) released from the pituitary. Transcripton of Tg gene 
requires thyroid-specific transcription factors TTF-1, TTF-2, and Pax-8, which bind to 
consensus sequence elements in the Tg promoter. From the 8.3 kb mRNA, Tg is initially 
synthesized in the endoplasmic reticulum (ER). Tg follows the secretory pathway, via the 
Golgi complex (Figure 1-1). In the ER, Tg polypeptide folding is initiated, and the 
protein acquires N-linked sugars and forms a homodimer. After modification of the N-
linked sugars in the Golgi complex, Tg is secreted by exocytosis from the apical plasma 
membrane of thyrocytes. Tg then enters the extracellular lumenal space of the thyroid 
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gland, surrounded by a tight monolayer of thyrocytes. Upon release at the plasma 
membrane, tyrosine residues on Tg become iodinated by thyroid peroxidase (TPO). This 
process requires hydrogen peroxide as an electron acceptor, which is generated by two 
members of the NADPH oxidase family (Duox1 and Duox2) on the apical membrane of 
thyrocytes (Figure 1-1). Iodide becomes available to TPO in the thyroid lumen by the 
action of a series of transporters that reside on the basolateral and apical membranes of 
thyrocytes. The sodium/iodide symporter is basolateral and assists in iodide uptake from 
the blood stream. The apical iodide transporter (AIT), pendrin, or other anion channels 
have been suggested to function as apical iodide transporters [2]. During the process of 
TPO-catalyzed iodination, there is specific coupling of di-iodinated tyrosyl residues of Tg. 
At this stage, thyroid hormones, thyroxine (T4) and triiodothyronine (T3) are still 
embedded within the Tg protein, which is stored at high concentration in the lumen of 
thyroid follicles. Secreted and stored Tg in the lumen exists primarily as non-covalent 
homodimers based on studies employing sucrose gradient centrifugation (19S, 660 kDa). 
To release T4 or T3 into the blood stream, Tg must be proteolyzed in lysosomes 
within thyrocytes. This is mediated by endocytosis of Tg from the follicle lumen. 
Considering the high concentration of iodinated Tg in the follicle, Tg re-uptake might 
involve fluid-phase endocytosis, which ordinarily does not require any specific receptors. 
Additionally, some proteins such as N-acetylglucosamine receptor, and megalin, have 
been described as putative endocytic receptors for Tg, although Tg endocytosis does not 
seem to depend strongly on such receptors. 
After release into blood, thyroxine (T4, which is the major circulatory thyroid 
hormone), binds to various transport proteins in the circulation. Thyroxine then becomes 
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available to be further activated by deiodination to triiodothyronine (T3) which is the 
most active form of the hormone. 
 
The structure of Tg 
Tg in mammals (e.g. human, rat, mouse, bovine, dog, cat) has been clearly 
identified and sequenced at the DNA level. Tg in all vertebrates has a similar, conserved 
protein structure. 
Overall, Tg is comprised of four regions (Figure 1-2A) [3]. The first three regions 
consist of multiple cysteine-rich repeat domains distinguished by their internal homology 
and exon-intron structure. These regions are called I, II, and III. The C-terminal region is 
homologous with the entirety of acetylcholinesterase and is called the ChEL domain 
(CholinEsterase-Like domain). 
Region I (Figure 1-2) encompassing the first ~1200 amino residues, has 10 of the 
11 “Tg type 1 repeats” that have either six cysteines within the repeat (type 1A) or four 
cysteines (type 1B). Tg type 1 repeat was named because it was first sequenced in Tg. 
The type 1 repeat occurs in multiple proteins in evolution, and its internal 3D structure 
has been characterized. But the structure of type 1 repeats within Tg have not been 
characterized in the context of the full protein. The Tg type 1 repeat found in other 
proteins (such as equistatin, nidogen, invariant chain and insulin-like growth factor-
binding protein families from sponge to vertebrates) functions in several ways, including 
as a cysteine protease inhibitor, as well as modulating insulin-like growth factor. The Tg 
type 1 repeat (especially 1A) has an even number of cysteines with a centered CWCV 
motif (also CHCA or CYCV in Tg) and a final cysteine (Figure 1-2B). These cysteines 
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form sequential intrachain disulfide bonds in the pattern as Cys1-Cys2, Cys3-Cys4, Cys5-
Cys6. Type 1A repeats are mostly common and and make three disulfide bonds; type 1B 
repeats have only four cysteines and make only two disulfide bonds (Figure 1-2B). 
Region II is a smaller region and contains three type 2 repeats (with two cysteines 
in each) as well as one final type 1 repeat (Figure 1-2). Region III has several type 3 
repeats with various numbers of cysteine (six cysteines for subtype “A” and eight for 
subtype “B”) (Figure 1-2). Type III repeats have no known homology with other proteins 
from current protein databases. Considering each repeat has an even number of cysteines, 
it seems highly likely that these cysteines are entirely consumed by intrachain disulfide 
bonds with “stapling” internally. Such a view is consistent with partial proteolytic 
digestion patterns using various proteases under native conditions, which tend to cleave 
between repeats [4]. 
The ChEL domain of Tg has ~28% identity with acetylcholinesterase [5, 6] 
(Figure 1-3) and with other cholinesterase-like proteins, called neuroligins (neuroligin 1 – 
4). The ChEL domain has six conserved cysteines forming three intrachain disulfide 
bonds that have been found to be critical to maintain the three dimensional structure of 
acetylcholinesterase (Figure 1-3). In addition, there is a high degree of conservation of 
amino acid residues lining the eight β-sheets that comprise the protein backbone (Figure 
1-4A). These and additional results strongly suggest that ChEL domain has a similar 
overall three dimensional structure to that of cholinesterase. However, amino acid 
residues of the catalytic triad of cholinesterase are not conserved in ChEL, which has 
been shown to lack cholinesterase activity (Figure 1-4A). What is the structural and 
functional importance of the cholinesterase-like domain of Tg, or, for that matter, other 
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cholinesterase-like proteins? Neuroligins, modulators of synapse formation, have recently 
been identified to have significant overlap of three dimensional structure with that of 
acetylcholinesterase [7-10] (Figure 1-4B). The cholinesterase-like domain of neuroligins 
does not have enzymatic activity but encodes a peptide interaction with a physiological 
partner, neurexin [11]. Indeed, even acetylcholinesterase maintains this peptide 
interaction function with other proteins such as a snake venom toxin, fasciculin [12] and 
other neuronal proteins [13]. 
Another interesting structural similarity shared by acetylcholinsterase and 
cholinesterase-like proteins is dimerization (Figure 1-4B). It is known that 
acetylcholinesterase can form a homodimer through the interaction between C-terminal 
helices of adjacent monomers, producing a four-helix bundle [14]. Recent structural 
studies reveal that neuroligins also form homodimers using the same four-helix bundle 
mechanism [7-10]. Conserved dimerizaton of acetylcholinesterase and neuroligins seems 
functionally important since mutations disrupting dimerization also prevent their function 
[11, 15]. Importantly, Tg also forms a homodimer and dimerization has been proposed to 
be a pre-requisite for its secretion [16]. Thus there is reason to think that the ChEL 
domain of Tg may also engage in both inter- and intra-molecular interactions. 
The most proximal Tg type 1 domain may not require the presence of downstream 
Tg domains in order to complete its folding because a severely truncated N-terminal 
fragment of Tg can be secreted [17]. It is notable that this N-terminal fragment contains 
the two tyrosines that have been found necessary to make most thyroid hormone. This 
may explain why hypothyroidism caused by early termination of translation in Tg, such 
as is seen Dutch goats, can be relieved by an ample supply of iodine in the diet [18]. But 
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such studies only underscore the question of the functional role of the ChEL domain in 
the context of the full length Tg protein. 
 
Tg folding in the endoplasmic reticulum – N-glycosylation and chaperone 
interaction 
As a secretory glycoprotein, polysomes direct newly translated Tg to the ER by 
virtue of its N-terminal signal peptide (19 – 20 amino acids). The nascent polypeptide of 
Tg is co-translationally translocated into the lumen of the ER through the Sec61 
translocon complex. Immediately after entry into the ER, secretory proteins with 
potential asparagine (N)-linked carbohydrate acceptor sites (N-X-S/T) may acquire core 
sugar modification by the action of oligosaccharyltransferase (OST), which transfers pre-
assembled glucose3-mannose9-N-acetylglucosamine2 (Glc3Man9GlcNAc2) core 
oligosaccharides from the ER membrane dolichol pyrophosphate intermediate to nascent 
polypeptides. Among the 20 potential glycosylation sites in human Tg, 16 sites are 
actually glycosylated [19] (13 among 14 in bovine Tg [20]). The number of 
oligosaccharides may vary (as in porcine Tg [21]), but approximately 10% of total mass 
of Tg (i.e., ~ 30 kDa of the 330 kDa Tg monomer) comes from covalently bound sugar. 
In the ER, the Glc3Man9GlcNAc2 core oligosaccharide gets further modified by 
trimming of three terminal glucoses by the sequential action of ER α-glucosidases I and 
II. At the stage when nascent polypeptides still contain monoglucosylated 
oligosaccharides, they start to interact with the lectin-like ER chaperones, calnexin and 
calreticulin. Calnexin is an integral membrane protein while calreticulin is contained 
within the ER lumen. Calnexin and calreticulin form chaperone complexes with ERp57, 
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an ER oxidoreductase that catalyzes formation and isomerization of disulfide bonds. (As 
a glycoprotein with abundant cysteine-rich domains, nascent Tg interacts with calnexin, 
calreticulin, and ERp57 during initial folding and such interaction is prevented by the 
drug castanospermine, which inhibits ER glucosidases and thereby prevents formation of 
the lectin binding site [22-24]). Tg also interacts with other chaperones such as protein 
disulfide isomerase (PDI) and immunoglobulin binding protein (BiP, also called GRP78). 
These interactions begin even before translation is finished [24, 25]. In addition to BiP, 
other glucose-regulated proteins such as GRP94 and GRP170 also interact with nascent 
Tg and they (including BiP) seem to prevent aggregation and premature secrection of Tg 
instead of directly facilitating folding [26, 27]. 
 
Tg folding in the ER – ER quality control and ER-associated degradation 
Further removal of the third and final glucose from monoglucosylated 
oligosaccharides by glucosidase II prevents glycoproteins from re-binding to calnexin 
and calreticulin. However, during folding in the ER, glucose can be re-added by the 
action of UDP-glucose: glycoprotein glucosyltransferase (UGGT), which senses non-
native (unfolded) polypeptides. This allows immature forms of glycoproteins to re-enter 
the ERp57/calnexin/calreticulin pathway, preventing the premature export of 
incompletely folded Tg. When Tg reaches its mature, native structure, it no longer 
associates with calnexin/calreticulin or other chaperones so that it is free to move forward 
from the ER to the Golgi complex. In contrast, misfolded glycoproteins which fail to 
reach a native conformation are cleared from the ER by a process called “ER-associated 
degradation” (ERAD). Terminal mannose residues on glycoproteins destined for ERAD 
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are involved in recognition and degradation of misfolded glycoproteins in part via the 
action of both ER-resident mannosidase I and anther ERAD enhancing α-mannosidase-
like protein (EDEM, Htm1p in yeast) [28, 29]. Inhibitors of mannosidase I such as 
deoxymannojirimycin and kifunensine prevent misfolded glycoproteins from interacting 
with EDEM, blocking their degradation. Current evidence suggests that ER-mannosidase 
I and EDEM are functional components in the ERAD of misfolded Tg [17, 30, 31]. 
Proteins can be degraded by proteases in the lysosome or by the ubiquitin-
proteasome system in the cytosol. Many misfolded secretory proteins degraded by ERAD 
employ the ubiquitin-proteasome system. As such, these proteins need to move back 
through the ER membrane so that proteasomes in the cytosol may gain access to them. 
This “retrotranslocation” across the ER membrane may require integral membrane 
proteins such as the Sec61 translocon [32]. But the true identity of the “retrotranslocon” 
is still controversial. Derlin-1 has also been proposed to be a retrotranslocon for ERAD 
[33]. To achieve retrotranslocation, misfolded proteins are expected to be fully unfolded 
to pass through the ER membrane, although there may be exceptions [34, 35]. BiP 
prevents aggregation of proteins in the ER and may help in retrotranslocation by 
maintaining misfolded proteins in a soluble state. PDI is also implicated as an unfoldase 
that can facilitate the retrotranslocation of misfolded secretory proteins as well as 
bacterial toxins [36]. Though PDI is one of the ER oxidoreductases with a thioredoxin 
motif (C-X-X-C), its actions are not limited to substrates with cysteines or disulfide 
bonds [37]. Recently, ERdj5 (with a J domain and four thioredoxin domains) has been 
reported as the first dedicated reductase to help retrotranslocation of ERAD substrates by 
reducing improper disulfide bonds [38]. Of the molecules mentioned above, degradation 
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of misfolded Tg requires the ubiquitin-proteasome system as ERAD of Tg is prevented 
by proteasome inhibitors [17, 30, 31]. Before ERAD, misfolded Tg has prolonged 
interactions with ER chaperones such as BiP, GRP94, calnexin, PDI, ERp57, and ERp72 
[17, 30, 39]. Interestingly, over-expression of PDI facilitates the degradation of misfolded 
Tg [40]. In this regard, misfolded Tg seems to be a prototypic ERAD substrate. 
 
Tg folding in the ER – ER stress and the unfolded protein response 
Under conditions of high expression and accumulation of misfolded 
secretory/membrane proteins in the ER (“ER stress”), cells employ various responses 
collectively called the “unfolded protein response (UPR)”. The function of the UPR is to 
alleviate ER stress [41]. The UPR is mediated by three different classes of signal 
transducers in the ER, inositol-requiring protein-1 (IRE1), activating transcription factor-
6 (ATF6), and protein kinase RNA (PKR)-like ER kinase (PERK). Each one is an 
integral membrane protein sensing the folding status in the lumen of the ER to elicit a 
stress-response pathway. IRE1 oligomerizes in the presence of a high concentration of 
unfolded proteins in the ER and trans-phosphorylates [42]. Oligomerization of IRE1 is 
induced either directly by unfolded proteins or indirectly via BiP binding to unfolded 
proteins and thereby releasing BiP inhibition of IRE1. Upon trans-phosphorylation, 
activated IRE1 uses its endonuclease domain to splice the mRNA of X-box binding 
protein-1 (XBP1, Hac1 in yeast). Translated XBP1, a transcriptional activator, increases 
the expression of UPR target genes. ATF6 is also retained in the ER by binding of BiP. 
The ER transmembrane form of ATF6 is also an inactivated form. Under ER stress, 
ATF6 is released from BiP and follows the secretory pathway to the Golgi, where it 
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encounters the site 1 protease (S1P) and then the site 2 protease (S2P). Release of the 
cytoplasmic domain of ATF6 to the cytosol allows this domain to move to the nucleus 
where it activates a subset of UPR genes. Finally, PERK is a type 1 transmembrane 
protein with a lumenal domain homologous to that of IRE1 that senses ER stress [43]. 
Under ER stress, PERK is liberated from BiP, oligomerizes, and trans-phosphorylates. 
PERK then becomes an active kinase that phosphorylates the α-subunit of eukaryotic 
translation initiation factor-2 (eIF2α) on Serine 51. The phosphorylated eIF2α suppresses 
further protein translation which helps cells limit proteins that could add to ER stress. 
Remarkably, the phosphorylated eIF2α actually allows for increased translation of ATF4 
which activates the expression of another subset of UPR genes, including the 
transcriptional factor CHOP (C/EBP-homologous protein). Genes increased in their 
expression as a consequence of UPR have been identified and many of them (more than 
50%) function in the secretory pathway [44]. 
 Cells employ UPR to relieve ER stress but under conditions in which UPR fails to 
handle the ER stress, cells die by apoptosis [45]. IRE1 can induce apoptosis via 
interaction of its cytoplasmic domain with tumor necrosis factor receptor-associated 
factor 2 (TRAF2). This interaction subsequently activates Jun kinase (JNK) which finally 
leads to apoptosis [46]. Caspase-12 has been described to be activated under ER stress 
and although it is not yet clear what mechanism induces caspase-12 activation, TRAF2 
has been described to interact with caspase-12. CHOP (positively expressed by ATF4) 
also activates genes which may potentiate apoptosis such as growth-arrest-and-DNA-
damage-34 (GADD34) and also suppresses the expression of anti-apoptotic Bcl-2. 
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 Perturbations of folding or increased expression of Tg can cause ER stress and 
thereby induce UPR [30, 47-49]. Under ER stress, thyroid cells show induced expression 
of multiple ER chaperones (e.g., calreticulin, BiP, GRP94, ERp29, ERp57, ERp72, and 
PDI) but not calnexin [30, 47-49]. Increased activities of UPR transducers (XBP1, ATF6, 
ATF4, and CHOP) also have been described under ER stress [47, 49]. ER stress activates 
JNK and nuclear factor-κB (NF-κB) in thyroid cell lines [50]. Dominant-negative TRAF2 
blocks the activation of NK-κB in thyroid cells under ER stress [50]. Ultimately, 
increased cell death is observed in thyroid tissue expressing certain misfolded form of Tg 
[30]. 
 
Tg mutations - Impact on health 
Disorders of thyroid function range from thyroid overactivity (hyperthyroidism, 
as exemplified by Graves’ disease) to hypothyroidism. Hypothyroidism is the most 
common thyroid disorder worldwide, and environmental iodine deficiency is still the 
most important underlying factor. But even in regions with sufficient dietary iodine, 
hypothyroidism, especially congenital hypothyroidism (occurring in 1 to 3,000 to 4,000 
live births), is one of the most common neonatal endocrine diseases [51]. Untreated 
congenital hypothyroidism can cause mental retardation and other growth disorders, 
which have historically been called “Cretinism” [51]. 
Congenital hypothyroidism is caused by either thyroid dysgenesis [52] or 
dyshormonogenesis which means a defect of thyroid hormone synthesis [53]. 
Considering the complicated pathway of thyroid hormone synthesis, it is not surprising 
that many genes have been identified as causing hypothyroidism. Thyroid-specific genes 
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with a defect in hormonogenesis include the TSH receptor, NIS, TPO, Pendred, Duox1, 
and Tg [53]. 
Tg mRNA is 8.5 kb; the size of the Tg gene is approximately 300 kb long and 
consisting of 48 exons [54, 55]. The large size may make the Tg gene unusually 
vulnerable to mutation. Currently, at least 39 inactivating mutations have been reported in 
human Tg (Table 1-1) [17, 56, 57]. Among these, 23 are missense mutations, 8 are 
splicing site mutations, 5 are nonsense mutations, and 3 are caused by single nucleotide 
deletion or insertion. Around 20% (eight mutations) are found within the ChEL domain 
of Tg. The disease phenotypes induced by these mutations vary from mild 
hypothyroidism to severe. Besides hypothyroidism, some mutations (C1058R, C1245R, 
C1977S, and G2356R) and polymorphisms (P2213L, W2482R, and R2511Q) have been 
suggested to be associated with thyroid cancer [58, 59]. Tg-related diseases have been 
reported also in animals such as cattle, goats, sheep, mice, rats, and antelope [56]. 
Specific Tg mutations causing the disease have been identified in Afrikander cattle 
(R697stop) [60], Dutch goat (Y296stop) [18], cog mouse (L2263P) [61], and rdw rat 
(G2300R) [62, 63]. 
Chronic autoimmune thyroiditis (e.g., Hashimoto’s disease), the most common 
organ autoimmune disease, is associated with antithyroglobulin antibodies in at least 60% 
of patients [64]. Thus Tg structure, folding, and antigenicity have definite 
pathophysiological significance. 
 
Phylogeny and ontogeny of thyroglobulin 
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The functional role of the thyroid hormone is well-described in mammals, 
especially in humans. For cold-blooded vertebrates, it still remains to be studied. Thyroid 
tissue is present in all vertebrates. In lamprey, thyroid tissue is not found in the larva 
period, but can be seen after metamorphosis to the adult. In non-vertebrates such as 
tunicates (Urochordata) and amphioxus (also known as lancelets, Cephalochordata), no 
homologous organ has been identified as thyroid tissue. But there are increasing reports 
showing that thyroid hormone functions in metamorphosis in these pre-vertebrates. Many 
homologous genes for thyroid hormonogenesis and function have been identified in 
amphioxus [65]. This suggests that the thyroid hormone system might have evolved 
earlier than the vertebrates. It is not yet clear whether or not there is a Tg-like gene in 
amphioxus (the genome sequencing has just been finished but its analysis is still to be 
done). But Tg-like iodoproteins have been identified in amphioxus and tunicates [66, 67]. 
Considering that most hormone synthesis occurs at the extreme N-terminus of Tg, 
it is an interesting question why Tg has evolved as a large molecule. As noted, the size 
may be disadvantageous because of increased susceptibility to inactivating mutations and 
autoimmunity. Studies suggest that gene duplication has been engaged in the evolution of 
Tg structure since 1) cysteine-rich units (type 1, 2, or 3) are present as repeats, 2) repeat, 
region, and domain boundaries are matched with intron-exon boundaries, and 3) domains 
with homologous type 1 repeats or homologous ChEL domains are found in many other 
proteins well before the appearance of vertebrates [68]. It has been suggested that Tg may 
have evolved for iodine storage (on tyrosine residues), which can be advantageous in an 
environment on land or fresh water where iodide is a trace element [69]. As noted above, 
Dutch goats, with an early termination mutation of Tg, still contains two major 
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hormonogenic sites that can produce thyroid hormone, but survival depends on 
abundance of dietary iodide [18]. This suggests that the full Tg molecule may be engaged 
as the central iodide reservoir in the body. 
 Non-mammalian Tg-like iodoproteins have similar sedimentation coefficients to 
those of mammalian Tg and have been described even in species where Tg has not yet 
been cloned [67, 70, 71]. Their amino acid compositions may differ among animals such 
as lamprey, fishes, reptiles, and mammals but it is notable that cysteine and tyrosine 
contents are surprisingly constant [70, 72].  
Genome sequencing projects recently finished from various taxonomic groups 
although sequence analysis is incomplete. From zebrafish a nearly full-sized Tg is 
predicted except for the 9th type I repeat domain (gene bank accession number, 
XP_694292). Two major hormonogenic tyrosines (Tyr5 and Tyr130) of mammalian Tg 
are also conserved in predicted zebrafish Tg. Moreover, region II, region III, and the 
ChEL domain are contained within predicted zebrafish Tg. Though incompletely 
characterized, regions II-III and ChEL and at least a portion of region I have thus far been 
DNA-sequenced in the Tg of two pufferfishes (Tetraodon nigroviridis and Takifugu 
rubripes). These are consistent with previous reports about the presence of Tg-like 
iodoproteins from teleosts [70, 72]. Further work is needed to trace the evolutionary 





Figure 1-1. Thyroid hormone synthesis. Thyrocytes are depicted in simplified view. 
The expression of thyroglobulin (Tg) is controlled under thyroid specific transcriptional 
factors such as TTF-1, TTF-2, and Pax-8 which is not shown in this figure. Translation of 
Tg is through the endoplasmic reticulum (ER) where glycosylation and folding of Tg 
occur. Also, major quality control of Tg is done in the ER. Note that most of Tg forms a 
homodimer in the ER. Tg dimer moves through the Golgi and gets further modification 
of oligosaccharide chains. Tg dimer is sorted in the TGN (trans-Golgi network) and 
secrets through the apical membrane of thyrocytes by exocytosis. Upon apical membrane, 
thyroid peroxidase (TPO) iodinates tyrosines of Tg in the presence of hydrogen peroxide 
(H2O2) generated by Duox1 and Duox2. TPO does following coupling reaction between 
two di-iodinated tyrosines from Tg to produce thyroxine (T4). Iodide is accumulated in 
the lumen of thyroid gland by a series of transporters such as sodium/iodide sympoter in 
the basolateral membrane and pendrin in the apical membrane. Iodide uptake can be 
happened in the same thyrocytes making Tg and is depicted here as in separated 
thyrocytes for presentation purpose. Triiodothyronine (T3) is also made in small amount. 
T4 (and T3) is still embedded within Tg. Free thyroid hormones (T4 and T3) are released 
from the lysosome where Tg taken by endocytosis is degraded. This pathway shows that 







Figure 1-2. The structure of thyroglobulin. (A) Protein structure of thyroglobulin (Tg). 
Region I consists of 10 type 1 repeats and is followed by region II having three 
consecutive type 2 repeats and 11th type 1 repeat. Region III has five type 3 repeats. The 
cholinesterase-like domain (ChEL domain) is at C-terminal end. Two major tyrosines 
(Tyr5 and Tyr130) to form thyroid hormone are shown in N-terminal area of Tg. SP – 
signal peptide. (B) Structure of cysteine-rich repeats (composing region I, II, and III) and 
ChEL domain. Type 1 repeats can be further categorized into type 1A (6 cysteines) and 
type 1B (4 cysteines). Type 2 repeats have 2 cysteines in each. Type 3 repeats have two 
kinds (type 3A with 6 cysteines and type3B with 8 cysteines). Region III has 3 type 3A 
and 2 type 3B in a way of A-B-A-B-A. The ChEL domain has 6 conserved cysteines with 
acetylcholinesterase (Figure 1-3). Cysteines in the repeat and ChEL domain are believed 
to form intrachain disulfide bonds within each repeat unit and domain. Total 122 
cysteines are in Tg and believed to form a maximum of 61 intrachain disulfide bonds. No 







Figure 1-3. Protein alignment between ChEL domains of Tg and 
acetylcholinesterases (AChE) from various of species. Alignment was performed using 
clustal X software (version 2.0.3) [73]. Colors indicate different homology among 
proteins, green (represents 100% identity), yellow (over 80%, lower 100%), and purple 
(over 60%, lower 80%). Boxes indicate conserved six cysteines in AChE and ChEL 
domain of Tg. Accession numbers used for alignment are P01266 (human Tg), 
CAA26584 (bovine Tg), NP_033401 (mouse Tg), P22303 (human AChE), NP_033729 





Figure 1-4. The structure of cholinesterase-like proteins. (A) Three dimensional 
structure of monomer of human AChE (PDB ID: 1B41). Coloring was done based on 
homology in figure 3 using Chemoffice 2006 (Cambridge Soft). Amino acid residues 
shown as ball and stick with red color are catalytic triad for AChE and none of them are 
conserved in ChEL domain of Tg. Note that high homology with ChEL of Tg is shown in 
the backbone structure (circled) in which most are colored with green (represents 100% 
identity, figure 3). (B) The homodimer structure of cholinesterase proteins. The molecule 
on the top is a dimer structure of mouse AChE (PDB ID: 1J07) and the one on the bottom 
is from mouse neuroligin 1 (NL1, PDB ID: 3B3Q). Other neuroligins (neuroligin 2 and 4) 
form a homodimer in similar way with NL1 [7-10]. Note that four-helix bundle (boxed), 




Table 1-1. List of human thyroglobulin gene mutations. This list is updated from 
previously described [56] by adding recent reports [17, 57]. 
Exon/intron position Nucleotide position Amino acid position 
Exon 2 c.113G>A p.R19K 
Intron 3 g.IVS3-3C>G Skipping of exon 4 
Exon 5 c548G>A p.C164Y 
Exon 5 c580T>G p.C175G 
intron 5 g.IVS5+1G>A Skipping of exon 5 
Exon 7 c.759-760insA p.L234fsX237 
Exon 7 c.886C>T p.R277X 
Exon 8 c.986A>C p.Q310P 
Exon 9 c.1143delC p.G362fsX382 
Exon 9 c.2131C>T p.Q692X 
Exon 10 c.2610G>T p.Q851H 
Intron 10 g.IVS10-1G>A Skipping of exon 11 
Exon 11 c.2969G>A p.S971I 
Exon 12 c.3022C>T p.R989C 
Exon 12 c.3035C>T p.P993L 
Exon 14 c.3229T>C p.C1058R 
Exon 17 c.3790T>C p.C1245R 
Exon 20 c.4310G>A p.W1418X 
Exon 21 c.4397G>A p.S1447N 
Exon 22 c.4537delG p.D1494fsX1547 
Exon 22 c.4588C>T p.R1511X or Skipping of exon 22 
Exon 24 c.4820G>T p.C1588F 
Intron 24 g.IVS24+1G>C Skipping of exon 24 
Intron 30 g.IVS30+1G>T Skipping of exon 30 
Intron 30 g.IVS30+1G>A Skipping of exon 30 
Exon 31 c.5690G>A p.C1878Y 
Exon 31 c.5791A>G p.I1912V 
Exon 33 c.5986T>A p.C1977S 
Exon 33 c.6017G>A p.C1987Y 
Intron 34 g.IVS34-1G>C Skipping of exon 35 
Exon 37 c.6461G>A p.C2135Y 
Exon 38 c.6701C>A p.A2215D 
Exon 38 c.6725G>A p.R2223H 
Exon 40 c.6956G>A p.G2300D 
Exon 40 c.7007G>A p.R2317Q 
Exon 41 c.7121G>T p.G2355V 
Exon 41 c.7123G>A p.G2356R 
Intron 45 g.IVS45+2T>A Skipping of exon 45 
Exon 46 c.7969C>T p.Q2638X 
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THE CHOLINESTERASE-LIKE DOMAIN OF THYROGLOBULIN 
FUNCTIONS AS AN INTRAMOLECULAR CHAPERONE 
 
Abstract 
Thyroid hormonogenesis requires secretion of thyroglobulin, a protein comprising 
Cys-rich regions I, II, and III (referred to collectively as region I-II-III) followed by a 
cholinesterase-like (ChEL) domain. Secretion of mature thyroglobulin requires extensive 
folding and glycosylation in the ER. Multiple reports have linked mutations in the ChEL 
domain to congenital hypothyroidism in humans and rodents; these mutations block 
thyroglobulin from exiting the ER and induce ER stress. We report that, in a cell-based 
system, mutations in the ChEL domain impaired folding of thyroglobulin region I-II-III. 
Truncated thyroglobulin devoid of the ChEL domain was incompetent for cellular export; 
however, a recombinant ChEL protein (―secretory ChEL‖) was secreted efficiently. 
Coexpression of secretory ChEL with truncated thyroglobulin increased intracellular 
folding, promoted oxidative maturation, and facilitated secretion of region I-II-III, 
indicating that the ChEL domain may function as an intramolecular chaperone. 
Additionally, we found that the I-II-III peptide was cosecreted and physically associated 
with secretory ChEL. A functional ChEL domain engineered to be retained intracellularly 
triggered oxidative maturation of I-II-III but coretained I-II-III, indicating that the ChEL 
domain may also function as a molecular escort. These insights into the role of the ChEL 
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Thyroid hormone is essential for development and oxidative metabolism in 
vertebrates. The synthesis of thyroid hormones involves secretion of thyroglobulin (Tg) 
to the apical extracellular lumen of follicles that serve as the basic functional unit of the 
thyroid gland. Once secreted, Tg is iodinated via the activity of a thyroid-specific 
peroxidase to form thyroxine (the major thyroid hormone) involving specific iodinated 
tyrosyl residues within the Tg polypeptide backbone [1]. No other endogenous proteins 
of the thyroid are capable of serving as precursors for thyroid hormone synthesis, 
rendering vertebrate organisms completely dependent on structural information encoded 
in the Tg molecule — both for directing iodotyrosyl coupling for thyroxine synthesis [2] 
and for passing ER quality control in the secretory pathway [3]. Cumulatively, steps 
leading to Tg export from the ER are rate limiting in its overall secretion [4]. Peak 
secretion of Tg, as measured in cell culture, occurs on the order of 3 hours after synthesis 
[5]. 
The Tg cDNA initially encodes 3 regions referred to collectively as region I-II-III, 
that span 80% of the full-length Tg monomer (2,746 amino acids in mouse Tg), with each 
region involving multiple Cys-rich repeat domains covalently ―stapled‖ by intradomain 
disulfide bonds [6]; while the final approximately 500 amino acids of Tg are strongly 
homologous to acetylcholinesterase [7-9]. The most important site of thyroxine synthesis 
involves but a small portion of the molecule at the extreme amino terminus of the Tg 
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protein [10, 11], raising questions about the role of the remaining C-terminal 2,250 amino 
acids [12]. Indeed, the overall structure of Tg remains unknown; nevertheless, it is clear 
that along its length, Tg undergoes extensive N-linked glycosylation and monomer 
folding in the ER [13]. 
Congenital hypothyroidism with defective Tg has been reported in species 
ranging from humans to rats and mice. In all 3 species, the cellular phenotype described 
includes a dilated ER with induction of ER molecular chaperones [14], activation of ER 
stress signaling pathways [15], and ER-associated degradation (ERAD) of most of the 
mutant Tg gene product [16]. Of the cases (and animal models) published to date, the 
cholinesterase-like (ChEL) domain is a very commonly affected site, involving mutations 
including the newly described A2215D [17, 18]; R2223H [19]; G2300D,R2317Q [20]; 
G2355V,G2356R; or the skipping of exon 45 (normally encoding 36 residues of the 
ChEL domain); as well as Q2638Z mutants (where Z represents stop) [21]. In addition 
are polymorphisms including P2213L and W2482R; and R2511Q that may be associated 
with an increased incidence of nonmedullary thyroid cancer [22]. Congenital 
hypothyroidism with defective Tg is caused by the G2300R point mutation localized to 
the ChEL domain in the rdw/rdw rat dwarf [23, 24], while we identified L2263P as 
responsible for the hypothyroidism of the cog/cog congenital goiter mouse [25]. Indeed, a 
truncated Tg comprising only region I-II-III and lacking the ChEL domain is blocked 
within the ER [26]. Together, these findings emphasize that in full-length Tg, a functional 
ChEL domain is needed to allow Tg to be efficiently transported to the site of thyroid 
hormone synthesis, in particular, for exit from the ER. 
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We show in this study, by contrast, that attaching a signal peptide to the ChEL 
domain is itself sufficient for rapid and efficient intracellular transport of that protein 
(―secretory ChEL‖) to the extracellular space. Moreover, by physical association with Tg 
I-II-III, secretory ChEL rescues in trans maximal protein expression, disulfide maturation, 
and secretion of Tg I-II-III. Indeed, intentional retention of the functional ChEL domain 
within the ER, while assisting in Tg I-II-III protein expression and disulfide maturation, 
prevents its intracellular transport. These data point to both a molecular chaperone and a 
molecular escort function of the ChEL domain in Tg transport for thyroid hormone 
synthesis. 
 
Materials and Methods 
Materials 
AMS (4-acetamido-4'-maleimidylstilbene-2,2'- disulfonic acid), Lipofectamine 
2000, fetal bovine serum, penicillin, and streptomycin were from Invitrogen; Complete 
protease inhibitor cocktail was from Roche; Brefeldin A, cycloheximide, N-
ethylmaleimide, protein G-Agarose, and protein A-Agarose from Sigma Chemical Co.; 
Endoglycosidase H and Peptide-N-Glycosidase F from New England Biolabs; Trans
35
S-
Label from MP Biomedicals; Zysorbin from Zymed Labs; TransIT-LT1 transfection 
reagent from Mirus. Rabbit polyclonal anti-myc was from Immunology Consultants, Inc. 
Rabbit polyclonal anti-Tg (containing antibodies against epitopes at both N- and C-
terminal regions of the protein) have been previously described [14]. 
 
Site-directed mutagenesis of mouse Tg cDNA 
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ChEL domain mutations were introduced with the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene) using the following mutagenic primers: ChEL-KDEL (5’–
GCCTGTCCCCAAGAGCTACAGCAAAGACGAGCTATAGGCCGCTTCCCTTTAG




ATGCTTCG –3’ and 5’–
CGAAGCATTAATCATAAGTCCTCCTCAGAGATCAGTTTCTGTTCTTTGCTGTA
GCTCTTG–3’). Truncated Tg region I-II-III was made by introducing a stop codon at 
L2169 (5’–GGAAGTCTGGAATCCCTTAGGTCCAATCTGATGTAACATCC–3’ and 
5’–GGATGTTACATCAGATTGGACCTAAGGGATTCCAGACTTCC–3’) within Tg 
subcloned into pCMS (BD Bioscience – Clontech). To make the secretory ChEL domain, 





G–3’) with subcloning into the Sal I and Not I sites of pCMS. Each mutation was 
confirmed by direct DNA sequencing before expression in 293 cells. The prolactin signal 
peptide in pSPPS1 (kind gift of Dr. V. Lingappa, U. California San Francisco) was fused 




Cell culture and transfection 
293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 
10% fetal bovine serum in 6 well plates at 37ºC in a humidified 5% CO2 incubator. 
Plasmids were transiently transfected using TransIT-LT1 or Lipofectamine 2000 
transfection reagent according to the manufacturer’s instructions. 
 
Metabolic labeling and immunoprecipitation 
Transfected 293 cells were starved for 30 min in met/cys-free DMEM, then pulse 
labeled with 180 μCi/ml 
35
S-amino acids for indicated time. The cells were then washed 
with an excess of cold Met/Cys and chased in complete DMEM. At each time point, cells 
were lysed in buffer containing 1% NP-40, 0.1% SDS, 0.1 M NaCl, 2 mM EDTA, 25 
mM Tris pH 7.4 and protease inhibitor cocktail. Where indicated, 20 mM N-
ethylmaleimide was also added to the lysis buffer. For immunoprecipitation, anti-Tg was 
incubated with cell or media samples overnight at 4ºC, and the immunoprecipitate was 
recovered with protein A-Agarose. For co-immunoprecipitation studies, samples were 
incubated overnight at 4ºC with anti-myc antibodies and protein A-Agarose. 
Immunoprecipitates (or co-precipitates) were washed three times before boiling in SDS 
sample buffer with or without reducing agent, resolved by SDS-PAGE, and analyzed by 
fluorography or phosphorimaging. 
 
Alkylation of Tg cysteine thiols 
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Immunoprecipitated Tg was resuspended and incubated in a buffer containing 2% 
SDS, 50 mM Tris pH7.4 with or without 5 mM AMS for 1 h at 30ºC. The reaction was 
stopped by boiling in SDS sample buffer plus 0.1 M DTT before analysis by SDS-PAGE. 
 
Endoglycosidase H or peptide-N-glycosidase digestion 
Immunoprecipitates were boiled for 10 min in denaturing solution with 0.5% SDS 
containing 1% 2-mercaptoethanol (for Peptide-N-Glycosidase digestion, solution with 0.5% 
SDS without reducing agent was used) and digested with 250 U of endoglycosidase H in 
50 mM sodium citrate, pH 5.5 or 250 U of Peptide-N-Glycosidase in 50 mM sodium 
phosphate, pH 7.5 with 1% NP-40 for 1 h at 37ºC. 
 
Results 
Maturation of recombinant Tg 
During folding, Tg must bury 122 free Cys thiols into intrachain disulfide bonds. 
Reactivity with 4-acetamido-4’-maleimidylstilbene-2,2’-disulphonic acid (AMS) 
irreversibly alkylates available Cys thiols, increasing by 0.5 kDa the protein molecular 
mass per alkylated Cys [27], which can ultimately be detected as a molecular mass shift 
by SDS-PAGE under reducing conditions. Upon denaturation, Tg secreted from cells 
(which had already passed ER quality control and received Golgi carbohydrate 
modifications) showed no detectable reactivity with 5 mM AMS (Figure 2-1, compare 
lanes 3 and 4). By contrast, newly synthesized intracellular Tg residing primarily in the 
ER [5] showed substantial AMS reactivity (compare lanes 5 and 6). Cells treated with 
brefeldin A (BFA; 5 μg/ml) accumulated in the ER newly synthesized Tg that, in terms of 
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AMS reactivity, seemed equivalent to the sum of secreted and intracellular Tg obtained 
from untreated cells, revealing the ability to discriminate between distinct folded states. 
In the case of the rdw mutant bearing the G2300R mutation within the ChEL domain of 
Tg, none of the Tg molecules in the population appeared able to properly mature, as 
judged by fact that they buried their Cys thiols (Figure 2-1). By 4% SDS-PAGE, a 
mobility shift of this magnitude (above that of the 330-kDa Tg band) suggests a 
molecular mass addition of 10–30 kDa, which might potentially represent modification of 
as many as 20–60 of the first 116 Cys residues of Tg. By contrast, the ChEL domain 
bearing the mutation has only 6 Cys residues – even modification of all of these residues 
would amount to a net molecular mass addition of only 3 kDa, which would not be 
expected to be seen as a significant mobility shift of the Tg band. Thus, these data imply 
that a mutation within the ChEL domain may impact on the ability to efficiently form 
disulfide bonds within upstream Tg region I-II-III, which contain the majority of Tg Cys 
residues. 
Recent studies have shown that for a brief period after synthesis, Tg newly 
synthesized by thyrocytes can be detected in mixed disulfides with a number of ER 
oxidoreductases: adducts known as forms A, B, and C that are detected by nonreducing 
SDS-PAGE [28]. Herein, we used nonreducing SDS-PAGE to examine disulfide 
maturation of recombinant mouse Tg upon transient expression in 293 cells. For wild-
type Tg, adducts in the A, B, and C region of the gel (like those reported for endogenous 
Tg; ref. [28]) could be seen, while an incompletely oxidized Tg monomer called band D 
was already the major species at the 0 chase time (Figure 2-2A, middle panel). By 1 hour 
of chase, the predominant Tg form was already a fully oxidized monomer called band E 
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(Figure 2-2A). Because secretion was ongoing, mature Tg was lost from these cells (data 
not shown). Under conditions where all forms of Tg were retained in the ER by treatment 
of cells with BFA, a quantitative profile of oxidative Tg folding intermediates could be 
observed (BFA; Figure 2-2A, right). 
Using PC Cl3 thyrocytes expressing endogenous Tg, we found that the newly 
identified E isoform is essentially identical to that secreted to the medium. What 
confounds the nonreducing SDS-PAGE analysis of Tg band mobility is the presence of 
Golgi-modified N-linked glycans on Tg (Figure 2-3A, right panel). Thus, a comparison 
of band mobility upon nonreducing SDS-PAGE can be made only after treatment with 
PNGase F to remove all N-linked oligosaccharides (Figure 2-3A, left panel; a double-
headed arrow establishes the identity of the E isoform in cells and media). Similar results 
were obtained for recombinant Tg expressed in 293 cells when examined without (Figure 
2-3B) or with (Figure 2-3C) prior PNGase F digestion. 
Tg monomer folding is temperature dependent [29], and Tg secretion is 
profoundly inhibited at both 20°C and 25°C. At 25°C, there was a slight increase in Tg 
adducts A, B, and C at the 0 chase time (Figure 2-2B, left). At 20°C there was additional 
prolongation of Tg adducts and further inhibition of Tg oxidative maturation from folding 
intermediate D to the mature E form (Figure 2-2B, right). With these results serving as 
positive controls for Tg folding, we proceeded to examine the oxidative maturation of 
both cog Tg and rdw Tg (which bear mutations in the ChEL domain). As shown in Figure 
2C, these proteins, even at 2 hours after synthesis, appeared arrested as early folding 
intermediates, including both Tg adducts and the incompletely oxidized D isoform. While 
we do not yet know the specific Tg Cys residues involved in either adduct formation or 
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maturation from D to E forms, these data further imply that function of the ChEL domain 
is crucial to global folding of the Tg molecule. 
 
The isolated ChEL domain folds autonomously in the secretory pathway 
The Tg ChEL domain exhibits substantial primary sequence similarity with 
authentic acetylcholinesterase, a well-studied protein [30] that is fully competent for 
intracellular transport to the cell surface. We therefore attempted to examine secretory 
behavior of the isolated ChEL domain driven into the ER via an artificial (prolactin) 
signal peptide. Indeed, within 4 hours after synthesis, the recombinant secretory ChEL 
protein was nearly completely released from cells as an endoglycosidase H–resistant 
species (Figure 2-4, lane 6), indicating that it traversed the intracellular transport pathway 
as a normal secretory protein. 
 
The ChEL domain is an intramolecular chaperone for Tg region I-II-III  
We previously reported that Tg region I-II-III is secretion incompetent [26]. To 
confirm this point, we followed the secretion and sensitivity to endoglycosidase H 
digestion of newly synthesized I-II-III 4 hours after synthesis. Indeed, while full-length 
wild-type Tg was efficiently secreted, I-II-III remained intracellular (Figure 2-5A). 
Persistence of sensitivity to endoglycosidase H digestion (Figure 2-5B) indicated that I-
II-III does not have sufficient information for efficient intracellular transport. This was 
also true even at extended chase times (Figure 2-5C, upper panel). These data support our 
previous hypothesis that the ChEL domain may be required for normal conformational 
maturation and intracellular transport of Tg [26]. 
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To better understand the relationship of the I-II-III domains to the ChEL domain, 
we coexpressed these as separate proteins within the ER. Remarkably, in trans, presence 
of the secretory ChEL domain in the ER rescued the export of I-II-III. This secretion was 
progressive over time (Figure 2-5C, lower panels). 
A likely implication of these findings is that I-II-III directly interacts with the 
ChEL domain. To examine this, we constructed a secretory ChEL with a carboxyterminal 
myc-epitope tag. Then either secretory ChEL or secretory ChEL-myc was coexpressed 
with I-II-III in 293 cells. After metabolic labeling, the chase medium bathing these cells 
was collected and evenly divided for immunoprecipitation with either anti-Tg or anti-myc 
(Figure 2-6A). Anti-Tg (lanes 1–3) directly immunoprecipitated both secretory ChEL (or 
ChEL-myc) as well as the rescued cosecreted I-II-III. Anti-myc (lanes 4–6) could not 
immunoprecipitate untagged ChEL and also failed to recover any I-II-III. However, anti-
myc immunoprecipitated secretory ChEL-myc and quantitatively coprecipitated all of the 
I-II-III (Figure 2-6A, lane 6) that could be directly immunoprecipitated with polyclonal 
anti-Tg (lane 3). 
These data strongly suggest that nearly 100% of secreted I-II-III associates with 
secretory ChEL within the ER and remains associated throughout the secretory pathway. 
Yet newly synthesized I-II-III is secreted with much slower kinetics than the cohort of 
labeled ChEL molecules synthesized at the same time (Figure 2-5C). I-II-III secretion 
must be dependent upon subsequently synthesized ChEL molecules, as post-pulse 
inhibition of further protein synthesis with cycloheximide (Figure 2-6B, lanes 3 and 4) 
blocked secretion of newly synthesized I-II-III even as it had no effect on the secretion of 
labeled ChEL. Thus, I-II-III is not ready to interact with ChEL when I-II-III is first made 
39 
 
but evidently needs preliminary folding to acquire competence for ChEL interaction. By 
contrast, ChEL export can proceed independently of I-II-III (Figure 2-4), decreasing its 
availability in the ER, which may limit efficiency of I-II-III transport (Figure 2-5C). To 
test this, we performed cotransfections of cDNAs encoding I-II-III and secretory ChEL at 
different plasmid ratios (with I-II-III cDNA and total DNA per transfection held constant). 
As shown in Figure 2-7A, increasing secretory ChEL cDNA increased the expression and 
secretion of the ChEL protein (bottom panel). Simultaneously, this also increased the 
quantity of I-II-III that was recovered intracellularly after a 6-hour chase, despite the fact 
that the transfection quantity of I-II-III cDNA was held constant (upper panel). As the 
initially synthesized I-II-III (0 chase time) was only marginally affected by coexpression 
of secretory ChEL (Figure 2-7B), it appears that most of the intracellular increase in I-II-
III protein reflects stabilization after synthesis. Indeed, we determined that total I-II-III 
recovery was increased 100% (i.e., doubled) at 16 hours of chase when secretory ChEL 
was expressed compared with vector DNA alone (Figure 2-7B). Accompanying the 
increased recovery in I-II-III was an increase in the amount of I-II-III secretion (Figure 2-
7A). 
If the ChEL domain were acting as a molecular chaperone for I-II-III, we 
reasoned that secretory ChEL might be able to enhance oxidative folding of I-II-III. To 
test this, we designed a secretory ChEL-KDEL construct, in which the KDEL sequence 
retains the ChEL domain in the early secretory pathway (discussed below). In a pulse-
chase format, presence of the ChEL-KDEL protein promoted disulfide maturation of I-II-
III from an incompletely oxidized intermediate (reminiscent of intermediate D of full-
length Tg; see Figure 2-2) to a more mature (E-like) form (Figure 2-8A, arrows). To 
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determine whether ChEL domain tertiary structure is required for oxidative rescue of I-II-
III, we compared the ChEL-KDEL construct with other secretory ChEL constructs 
bearing cog or rdw mutations, which are also retained within the early secretory pathway. 
As shown in Figure 2-8B, unlike ChEL-KDEL, these mutations within the ChEL domain 
had little or no beneficial effect on oxidative maturation of I-II-III. By contrast, authentic 
secretory ChEL (without KDEL) promoted secretion of I-II-III protein that, after 
deglycosylation with PNGase F, exhibited oxidative maturation comparable to that of the 
mature E form seen intracellularly (Figure 2-9). Together, the data in Figure 2-8 and 
Figure 2-9 strongly suggest that a native ChEL domain acts like an intramolecular 
chaperone, facilitating oxidative maturation of upstream Tg domains. 
 
The ChEL domain is a molecular escort for Tg region I-II-III 
If the ChEL domain serves only as a true molecular chaperone within Tg, then we 
would expect that when expressed in trans, secretory ChEL (like other molecular 
chaperones) would show a binding preference for early I-II-III folding intermediates over 
fully mature molecules. To examine this, we coimmunoprecipitated intracellular I-II-III 
with secretory ChEL-myc in cells treated with BFA to block intracellular transport in the 
secretory pathway. In the absence of ChEL, I-II-III exhibited defective oxidative 
maturation (Figure 2-10, lanes 2–4), while in the presence of secretory ChEL-myc, anti-
Tg directly and efficiently immunoprecipitated both immature D and mature E forms of 
I-II-III (lanes 5–7). The presence of ChEL appeared to increase recovery of I-II-III, 
consistent with results shown in Figure 7. By contrast, the immunoprecipitation of ChEL 
with anti-myc seemed inefficient at coprecipitation of the unfolded I-II-III isomer, as 
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compared with the efficient recovery of the faster-migrating, mature I-II-III (Figure 2-10, 
lanes 9 and 10). These data along with the persistent ChEL association with I-II-III even 
after secretion (Figure 2-6A) indicate that ChEL serves as more than an intramolecular 
chaperone for unfolded Tg molecules. If indeed the ChEL domain helps to physically 
convey I-II-III export from the ER, then if ChEL transport were to be disrupted, I-II-III 
transport would be disrupted in parallel. This proved to be the case, as unlike secretory 
ChEL, secretory ChEL-KDEL permitted secretion of I-II-III only to the extent that the 
ChEL-KDEL itself escaped from the cells (Figure 2-11, A and B), despite the fact that 
ChEL-KDEL facilitated the oxidative maturation of I-II-III (Figure 2-8). As predicted by 
results in Figure 8B, secretory ChEL bearing cog or rdw mutations also did not support I-
II-III secretion (Figure 2-11B), just as these mutations do not permit secretion of intact 
Tg. Together, the data indicate that the ChEL domain functions as both an intramolecular 
chaperone and molecular escort for Tg maturation and transport in the secretory pathway. 
 
Discussion 
Tg has evolved as the unique protein precursor for thyroid hormone synthesis. 
Specially encoded structural features for thyroid hormone formation and iodide storage [2] 
are known to come into play once the Tg molecule has been delivered extracellularly, 
where it comes in contact with the thyroidal iodination machinery [31]. However, 
structural features encoding Tg transport in the secretory pathway – required for Tg to 
serve as a prohormone – have been more elusive. In spite of this, it appears that most 
congenital hypothyroidism with deficient Tg is caused by mutations in which 
intracellular Tg transport is blocked, rather than by defects in the ability to synthesize 
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thyroid hormone per se [1, 32]. Evolutionary pressure definitely exists for Tg to be 
maintained as a secreted protein, as its inability to do so (at least in Merino sheep) 
compromises viability to a stage where animals cannot reach reproductive age [33, 34]. 
We now present what we believe to be the first evidence directly implicating the ChEL 
domain in assisting the intracellular protein transport of Tg.  
One way in which the ChEL domain may participate in Tg export is by 
facilitating Tg folding. We previously suspected that ChEL forms an independently 
folded domain within Tg, because its replacement by authentic acetylcholinesterase 
results in a chimera with active cholinesterase function [26]. Yet single point mutations in 
the ChEL region appear sufficient to prevent formation of disulfide bonds that are made 
in upstream Tg regions, as evidenced not only by remarkable reactivity with AMS 
(Figure 2-1), but also by direct assessment of global disulfide maturation (with cog and 
rdw mutants being trapped in partially oxidized folding intermediates; Figure 2-2). Using 
a cleavable signal peptide, we now find that the isolated ChEL domain is a very effective 
secretory protein in its own right (Figure 2-4), whereas I-II-III alone cannot escape ER 
retention (Figure 2-5, A and B). The simplest hypothesis (still to be tested) is that 
exposed chaperone-binding regions on Tg I-II-III confers its ER retention. Remarkably, 
our current evidence supports that the presence of the ChEL domain in the ER enriches 
for an oxidatively mature form of I-II-III (Figure 2-8), increases intracellular recovery of 
I-II-III (Figure 2-7 and Figure 2-10), and allows I-II-III to be secreted (Figure 2-5C) in a 
form that is both endoglycosidase H resistant (data not shown) and appropriately oxidized 
(Figure 2-9). Thus, we propose that as long as the ChEL domain is itself properly folded 
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(Figure 2-11B), it functions as an intramolecular chaperone within the context of full-
length Tg, facilitating the efficiency of ―on-pathway‖ protein folding, leading to ER exit.  
However, this does not appear to be the whole story, because the ChEL domain is 
transported with Tg out of the ER. Surprisingly, this is not simply because the ChEL 
domain is physically contiguous within the Tg protein. Indeed, secretory ChEL, made as 
a separate protein, is engaged in a direct physical interaction with I-II-III throughout the 
secretory pathway and into the extracellular space (Figure 2-6A). Nevertheless, most 
newly synthesized I-II-III does not exit the ER with a secretory ChEL partner that was 
synthesized during the same pulse-labeling period. Rather, the kinetics of I-II-III 
secretion are delayed in comparison to the speedy (and efficient) release of coexpressed 
secretory ChEL (Figure 2-5C). Evidently, intracellular transport of I-II-III must wait for 
subsequently translated ChEL domain to become available for interaction (Figure 2-6B). 
Thus, in all likelihood, I-II-III must undergo some preliminary folding prior to its 
interaction with ChEL. Indeed, the ChEL domain has an even stronger affinity for well-
folded I-II-III than it does for immature I-II-III (Figure 2-10). This binding is not 
accidental but essential to the Tg secretory process. Specifically, retention of ChEL 
within the ER-Golgi system via an engineered KDEL sequence co-retains the mature I-II-
III (Figure 2-11) – even as it permits the ChEL domain to function normally as a 
molecular chaperone (Figure 2-8). Thus, we are forced to conclude that the ChEL domain 
also functions as a molecular escort [3] required to convey Tg I-II-III out of the ER.  
It is interesting to consider the evolutionary dependence of Tg on these 
mechanisms of intramolecular rescue, given that the major thyroid hormone–forming site 
in Tg is at its extreme amino terminus [35]. One might predict that a highly truncated Tg 
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with fewer disulfide bonds and preservation of crucial amino acids for thyroid hormone 
formation [10, 11] would allow survival without the need of intramolecular chaperone or 
escort functions. Indeed, there is speculation that such a short aminoterminal portion of 
Tg may be all that is required for human survival, which requires ongoing thyroid 
hormone synthesis [36]. However, evolutionary and environmental circumstances (i.e., 
iodide unavailability on the earth’s crust) have promoted development of a more complex 
Tg structure for iodide storage in vertebrate organisms [1].  
In summary, we propose that intracellular Tg transport for thyroid hormone 
synthesis is dependent on intramolecular chaperone and escort functions embedded 
within its ChEL domain. 
 
Acknowledgements 
 This work was supported by National Institutes of Health grant DK40344 (to Dr. 
P. Arvan). I would like to thank Dr. V. Lingappa (U. of California San Francisco) for the 
prolactin signal peptide in pSPPS1. We also thank members of the Arvan laboratory, 
especially Xiang Zhao, for helpful suggestions during the course of this work. This work 





Figure 2-1. Free Cys thiols in Tg. 293 cells were transiently transfected with an 
expression vector encoding wild-type Tg, the rdw Tg mutant (G2300R), or empty vector. 
At 48 hours after transfection, cells were pulse labeled for 30 minutes with 
35
S-labeled 
amino acids and chased for 4 hours in the absence or presence of BFA (5 μg/ml) where 
indicated. At this time, chase media (lanes labeled ―Tg secreted‖) and cell lysates (all 
other lanes) were immunoprecipitated with anti-Tg. The immunoprecipitates were 
denatured in 2× SDS gel sample buffer lacking reducing agents and mock incubated or 
incubated with AMS (5 mM, 30°C for 1 hour). At the end of the incubation, samples 
were boiled in the presence of 20 mM DTT and analyzed by 4% SDS-PAGE and 
fluorography. A slowed mobility (shift up) of the Tg band after AMS is indicative of free 






Figure 2-2. Arrested disulfide maturation of Tg bearing a mutation in the ChEL 
domain. (A) 293 cells were transiently transfected with vector DNA encoding wild-type 
Tg (bearing a C-terminal myc-6xHis epitope tag that does not block Tg secretion; ref. 
[37]) or empty vector (control [Con]). Transfected cells were then pulse labeled for 30 
minutes with 
35
S-labeled amino acids and chased at 37°C for up to 4 hours in the absence 
or presence of BFA (5 μg/ml) where indicated. At each chase time, cells were lysed, 
immunoprecipitated with anti-Tg, and analyzed by nonreducing 4% SDS-PAGE and 
fluorography. A region of the gel enriched in disulfide-linked Tg adducts A, B, and C [28] 
is indicated. Two additional forms of Tg monomer – folding intermediate D and the E 
band representing fully oxidized mature Tg – are shown. (B) Results of an experiment 
identical to the one represented in A, except that the cells were chased at either 25°C (left) 
or 20°C (right). At each time, chase medium was also collected (as indicated), but at 
these temperatures the media contained no labeled Tg. (C) Results of an experiment 
identical to the one represented in A, except that cells were transfected with plasmid 
DNA encoding cog (L2263P) or rdw (G2300R) mutations within the Tg ChEL domain, 
and the cell lysis buffer included 20 mM N-ethylmaleimide. No detectable Tg was 





Figure 2-3. Oxidation state of secreted Tg. At each chase time, cells were lysed in 
buffer including 20 mM N-ethylmaleimide, and the lysates and chase media 
immunoprecipitated with anti-Tg and analyzed by nonreducing 4% SDS-PAGE and 
fluorography. (A) PC Cl3 cells were pulse labeled for 10 minutes with 
35
S-labeled amino 
acids and then chased for the times indicated. Immunoprecipitates were either undigested 
or digested with PNGase F as indicated. Folding intermediates A, B, and C, which have 
been characterized in previous studies [28], are shown. Also identifed are 2 closely 
spaced Tg disulfide isomer bands labeled D and E, respectively. Because of glycosylation 
differences, the mature E isoform does not comigrate with Tg secreted to the medium at 1 
hour of chasing. After PNGase F digestion to remove N-glycans, all Tg forms exhibit a 
faster (shifted-down) mobility. Under these conditions, it is now apparent that secreted 
Tg comigrates with the intracellular E isomer, identifying the most oxidized band as the 
most mature folded form of Tg. (B) Results of an experiment identical to the one 
represented in A, except using recombinant Tg expressed in 293 cells, without PNGase F 
digestion. (C) Results of a repeat experiment of that shown in panel B, but including 
PNGase F digestion. The position of a 181-kDa prestained molecular weight standard is 




Figure 2-4. Efficient exit of the isolated Tg ChEL domain from the ER. 293 cells 
were transiently transfected with a plasmid encoding the wild-type mouse Tg ChEL 
domain preceded by the prolactin signal peptide (Secretory ChEL) or were untransfected 
(293 control). Cells were pulse labeled for 30 minutes with 
35
S-labeled amino acids and 
chased for 0 or 4 hours as indicated, at which time the cells were lysed and both lysates 
and media immunoprecipitated with a rabbit polyclonal anti-Tg. Immunoprecipitates 
from transfected cells were divided in 2 equal portions and either mock digested or 
digested with endoglycosidase H (Endo H). Finally, all samples were analyzed by 
reducing 5.5% SDS-PAGE and fluorography. The band shift observed after digestion of 
secretory ChEL from the 0 chase time (shift down, lane 2) is indicative of 
endoglycosidase H sensitivity and defines ChEL that has not yet reached the Golgi 
complex; in contrast, none of the secreted ChEL shows the same endoglycosidase H 
sensitivity, indicating intracellular transport via the Golgi complex. The lanes shown 
were all run on the same gel, although they are presented noncontiguously. The position 






Figure 2-5. ER exit of Tg region I-II-III in the absence and presence of ChEL 
domain. (A) 293 cells were either untransfected (control) or transiently transfected with 
2 μg plasmid DNA encoding either full-length wild-type mouse Tg or Tg region I-II-III. 
Cells were pulse labeled and chased and samples prepared and immunoprecipitated with 
anti-Tg as in Figure 4, with analysis by reducing 4% SDS-PAGE and fluorography. 
Arrows highlight secretion (or lack thereof) from cells to media. (B) The first lane 
represents untransfected control cells. The remaining cells transfected to express Tg 
region I-II-III were pulse labeled as in A and then lysed without or with 4 hours of 
chasing. Tg immunoprecipitates from cell lysates and media were either mock digested or 
digested with endoglycosidase H for 1 hour at 37°C, before reducing 4% SDS-PAGE and 
fluorography. Lanes were run contiguously but have been separated for clarity. The 
positions of molecular mass standards are shown at left. (C) Lower panels: 293 cells were 
transiently transfected with 0.5 μg plasmid DNA encoding I-II-III cotransfected with 2.5 
μg of plasmid DNA encoding the secretory ChEL domain or untransfected controls. Cells 
were pulse labeled for 30 minutes with 
35
S-labeled amino acids and chased for the times 
indicated. At each chase time, the cells were lysed and both lysates and media 
immunoprecipitated with polyclonal anti-Tg to recover both I-II-III and secretory ChEL 
proteins, as revealed by reducing 5.5% SDS-PAGE and fluorography. The upper panel 
represents a negative control with identical transfection of I-II-III but without 





Figure 2-6. Secreted I-II-III protein is physically associated with secretory ChEL 
protein. (A) 293 cells were transiently transfected with 0.5 μg plasmid DNA encoding I-
II-III and cotransfected with 2.5 μg of plasmid DNA encoding the secretory ChEL 
domain either lacking or containing a myc epitope tag, as indicated. The cotransfected 
cells or untransfected controls were pulse labeled for 30 minutes and chased in complete 
media, and the secretion after 6 hours was analyzed by immunoprecipitation with anti-Tg 
or anti-myc. Immunoprecipitates and coprecipitates were analyzed by reducing 5.5% 
SDS-PAGE and fluorography. Addition of the myc tag slightly retards the SDS-PAGE 
mobility of the ChEL domain. Note that anti-myc precipitation of ChEL-myc 
coprecipitates I-II-III. (B) Cells untransfected (control) or cotransfected and pulse labeled 
as in A (I-II-III + ChEL) were chased in complete media for the time intervals shown, in 
the presence or absence of cycloheximide (CHX). The media were immunoprecipitated 
with anti-Tg and analyzed by reducing SDS-PAGE and fluorography. These lanes were 
run contiguously; a black line has been added for clarity to separate the samples. Note 
that prelabeled ChEL secretion proceeded rapidly in the presence of CHX, but prelabeled 






Figure 2-7. ChEL interaction improves recovery as well as secretion of Tg I-II-III. 
(A) 293 cells were triply transfected with empty vector plus a plasmid encoding Tg 
region I-II-III (always 0.1 μg DNA per well) plus a plasmid encoding the secretory ChEL 
domain (at different DNA levels as shown). DNA in each transfection totaled 3.1 μg per 
well. Transfected cells were pulse labeled for 30 minutes with 
35
S-labeled amino acids 
and chased for 6 hours, at which time the cells were lysed, and both lysates and media 
were immunoprecipitated with anti-Tg and analyzed by reducing 5.5% SDS-PAGE and 
fluorography, as shown. The position of a 76-kDa molecular mass marker is shown at left. 
The figure has been spliced at the position indicated by a black line (between lanes 2 and 
3), but all data were derived from a single exposure of the same gel. (B) Cells were either 
untransfected or transfected with 0.5 μg plasmid DNA encoding I-II-III plus 2.5 μg of 
vector DNA or that encoding secretory ChEL. As a positive control, 2 μg of plasmid 
DNA encoding wild-type Tg was transfected in parallel. Cells were pulse labeled for 30 
minutes with 
35
S-labeled amino acids and chased for either 0 or 16 hours, at which time 
the cells were lysed and both lysates and media immunoprecipitated with anti-Tg and 
analyzed by reducing 5.5% SDS-PAGE and phosphorimaging, as shown. The 
intracellular band density at the 0 chase time was defined as 100%; based on this, the 
recovery of each band at 16 hours is shown. Total recovery of labeled I-II-III alone at 16 
hours was approximately 35%, while total recovery of labeled I-II-III (cells plus media) 





Figure 2-8. ChEL functions as a molecular chaperone for I-II-III. (A) Cells were 
either untransfected (control) or transfected with a plasmid encoding I-II-III plus either 
empty vector or secretory ChEL-KDEL, as indicated. The transfected cells were pulse 
labeled for 30 minutes with 
35
S-labeled amino acids and chased for the times indicated. 
At each chase time, cells were immunoprecipitated with anti-Tg and newly synthesized I-
II-III analyzed by nonreducing 4% SDS-PAGE and fluorography. Absence of recovery of 
I-II-III from untransfected control cells is shown at left. The band seen at time 0 and after 
chasing for 2 hours appears equivalent to that of the D isoform of full-length Tg. In the 
presence of the ChEL domain in the ER, a faster-migrating band equivalent to that of the 
mature E isoform of full-length Tg is detected (filled arrow). (B) Results of an 
experiment using the same cotransfection protocol and analysis as in A, except the 
second plasmid is either vector alone or secretory ChEL domain containing the cog 
mutation, the rdw mutation, or the KDEL appendage. Absence of recovery of I-II-III 
from untransfected 293 cells is shown in lane 1. The position of a 176-kDa molecular 





Figure 2-9. Oxidation state of secreted I-II-III. 293 cells were transfected either with 
empty vector (control) or with secretory ChEL bearing or lacking the KDEL appendage. 
The cells were pulse labeled for 30 min with 
35
S-labeled amino acids and then chased for 
the times indicated (control cells were chased for 2 hours). The cells were lysed, and both 
lysates and chase medium immunoprecipitated with anti-Tg and subjected to PNGase F 
digestion to remove N-glycans. The samples were then analyzed by nonreducing 5.5% 
SDS-PAGE. Under these conditions, it is apparent that secreted I-II-III closely migrates 
with the intracellular E isomer of I-II-III. A black line has been added to distinguish the 






Figure 2-10. Intracellular association of secretory ChEL with I-II-III. 293 cells were 
transfected with empty vector or with plasmid DNAs encoding I-II-III (0.5 μg) plus 1.5 
μg of either vector alone (I-II-III) or secretory ChEL with an appended myc epitope tag 
(ChEL-myc). All cells were pulse labeled for 30 minutes with 
35
S-labeled amino acids 
and chased for the times shown in the presence of BFA (5 μg/ml). The cells were lysed 
and immunoprecipitated either anti-Tg (lanes 1–7) or anti-myc (lanes 8–11). 
Immunoprecipitates were analyzed by nonreducing 5.5% SDSPAGE and fluorography, 
with the I-II-III region shown. The I-II-III band seen at time 0 appears equivalent to that 
of the D isoform, while ChELmyc favorably coprecipitates a faster-migrating band 
equivalent to that of the mature E isoform (arrow). The position of a 176-kDa molecular 







Figure 2-11. The Tg ChEL domain functions as a molecular escort. (A) 293 cells 
were untransfected or transiently cotransfected with 0.5 μg plasmid DNA encoding I-II-
III plus 2.5 μg of the constructs indicated. The cells were pulse labeled for 30 minutes 
with 
35
S-labeled amino acids and chased in complete medium for 4 hours. Cell lysates 
and media were immunoprecipitated with anti-Tg and analyzed by SDS-PAGE and 
fluorography. Note that anti-Tg recognizes both I-II-III and the ChEL protein; the ChEL-
KDEL construct is selectively retained intracellularly, while secretory ChEL is released 
to the medium. Intracellular retention of ChEL-KDEL causes a parallel retention of I-II-
III. (B) Cells cotransfected and pulse labeled as in A were chased for 5 hours before 
analysis as above. Note that the secretory ChEL domain bearing the cog or rdw mutation 
cannot support the secretion of I-II-III. The positions of molecular mass markers are 
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THE CHOLINESTERASE-LIKE DOMAIN OF THYROGLOBULIN, 
ESSENTIAL IN THYROGLOBULIN TRAFFICKING FOR THYROID 
HORMONE SYNTHESIS, IS REQUIRED FOR PROTEIN DIMERIZATION 
 
Abstract 
The carboxyl-terminal cholinesterase-like (ChEL) domain of thyroglobulin (Tg) 
has been identified as critically important in Tg export from the endoplasmic reticulum. 
In a number of human kindreds suffering from congenital hypothyroidism and in the cog 
congenital goiter mouse and rdw rat dwarf models, thyroid hormone synthesis is inhibited 
because of mutations in the ChEL domain that block protein export from the endoplasmic 
reticulum. We hypothesize that Tg forms homodimers through noncovalent interactions 
involving two predicted alpha helices in the ChEL domain that are homologous to the 
dimerization helices of acetylcholinesterase. This has been explored through selective 
epitope tagging of dimerization partners, and by inserting an extra, unpaired Cys residue 
to create an opportunity for intermolecular disulfide pairing. We show that the ChEL 
domain is necessary and sufficient for Tg dimerization; specifically, the isolated ChEL 
domain can dimerize with full-length Tg or with itself. Insertion of an N-linked glycan 
into the putative upstream dimerization helix blocks detectable homodimerization of the 
isolated ChEL domain. However, interestingly, co-expression of upstream Tg domains, 
either in cis or in trans, overrides the dimerization defect of such a mutant. Thus, while 
the ChEL domain provides a nidus for Tg dimerization, interactions of upstream Tg 
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The synthesis of thyroid hormone in the thyroid gland requires secretion of 
thyroglobulin (Tg) to the apical luminal cavity of thyroid follicles [1]. Once secreted, Tg 
is iodinated via the activity of thyroid peroxidase [2], followed by a coupling reaction 
involving a quinol-ether linkage especially engaging di-iodinated tyrosyl residues 5 and 
130 to form thyroxine within the amino-terminal portion of the Tg polypeptide [3, 4]. 
Preferential iodination of Tg hormonogenic sites is dependent not on the specificity of the 
peroxidase [5] but on the native structure of Tg [6]. To date, no other thyroidal proteins 
have been shown to effectively substitute in this role for Tg. 
The first 80% of the primary structure of Tg (full-length murine Tg: 2,746 amino 
acids) involves three regions called I-II-III comprised of disulfide-rich repeat domains 
held together by intradomain disulfide bonds [7, 8]. The final 580 amino acids of Tg are 
strongly homologous to acetylcholinesterase [9-11]. Rate-limiting steps in the overall 
process of Tg secretion involve structural maturation within the endoplasmic reticulum 
(ER) [12]. Interactions between regions I-II-III and the cholinesterase-like (ChEL) 
domain have recently been suggested to be important in this process, with ChEL 
functioning as an intramolecular chaperone and escort for I-II-III export [13]. In addition, 
Tg conformational maturation culminates in Tg homodimerization [14, 15] with 
progression to a cylindrical and ultimately, a compact ovoid structure [16-18]. 
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In human congenital hypothyroidism with deficient Tg, the ChEL domain is a 
commonly affected site of mutation, including the recently-described A2215D [19, 20], 
R2223H [21], G2300D, R2317Q [22], G2355V, G2356R, and the skipping of exon 45 
(which normally encodes 36 amino acids), as well as the Q2638stop mutant [23] (in 
addition to polymorphisms including P2213L, W2482R, and R2511Q that may be 
associated with thyroid overgrowth [24]). As best as is currently known, all of the 
congenital hypothyroidism-inducing Tg mutants are defective for intracellular transport 
[25]. A homozygous G2300R mutation (equivalent to residue 2298 of mouse Tg) in the 
ChEL domain is responsible for congenital hypothyroidism in rdw rats [26, 27], whereas 
we identified the Tg-L2263P point mutation as the cause of hypothyroidism in the cog 
mouse [28]. Such mutations perturb intradomain structure [29] and interestingly, block 
homodimerization [30]. Acquisition of quaternary structure has long been thought to be a 
prerequisite for efficient export from the ER [31] as exemplified by authentic 
acetylcholinesterase [32, 33] in which dimerization enhances protein stability and export 
[34]. 
Tg comprised only of regions I-II-III (truncated to lack the ChEL domain) is 
blocked within the ER [29] while a secretory version of the isolated ChEL domain of Tg 
devoid of I-II-III undergoes rapid and efficient intracellular transport and secretion [13]. 
Given the striking homology that positions two predicted alpha helices of the ChEL 
domain to the identical relative positions of the dimerization helices of 
acetylcholinesterase, these recent findings raise the possibility that ChEL may function as 
the homodimerization domain of Tg, providing a critical function in maturation for Tg 
transport to the site of thyroid hormone synthesis [1]. 
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In this chapter, we provide unequivocal evidence for homodimerization of the 
ChEL domain and “hetero”-dimerization of that domain with full-length Tg, and we 
provide suggestive evidence that the predicted ChEL dimerization helices provide a nidus 
for Tg assembly. On the other hand, our data also suggest that upstream Tg regions 
known to interact with ChEL [13] actively stabilize the Tg dimer complex. Together, I-II-
III and ChEL provide unique contributions to the process of intracellular transport of Tg 
through the secretory pathway. 
 
Materials and Methods 
Materials 
Lipofectamine 2000, Dulbecco’s modified Eagle’s medium (DMEM), Zysorbin, 
fetal bovine serum, penicillin, and streptomycin were from Invitrogen; Complete protease 
inhibitor cocktail was from Roche; Brefeldin A, protein G-Agarose, and protein A-
Agarose from Sigma Chemical Co.; Endoglycosidase H from New England Biolabs; 
Trans
35
S-Label from MP Biomedicals; TransIT-LT1 transfection reagent from Mirus. 
Rabbit polyclonal anti-myc and anti-GFP were from Immunology Consultants, Inc., 
monoclonal anti-acetylcholinesterase (MAB303) from Milipore, and monoclonal anti-HA 
(MMS-101P) from Covance. Rabbit polyclonal anti-Tg (containing antibodies against 
epitopes at both N- and Cterminal regions of the protein) has been previously described 
[30]. 
 
Site-directed mutagenesis of mouse Tg cDNA 
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ChEL domain mutations were introduced with the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene) using the following mutagenic primers (paired with their 
complements): D2708C/G2709stop  in Tg (“Tg-CD”, 5’-
CCAGACTTTGAAGGATGCATGTTGAGCCAAGGATGCACAGTTAACC-3’); 




ATGCTTCG –3’); ChEL-HA (5’- 
CCAAGAGCTACAGCAAATACCCTTACGACGTCCCCGATTACGCGTAGGTTAA
TGCTTCGC-3’). Truncated Tg regions I-II-III and secretory ChEL were made as 
described previously [13]. I-II-III-myc and -HA were made using the following primers 
and their complements (5’- 
CCGGAAGTCTGAACAGAAGTTGATCTCAGAGGAGGACCTATAGACACCTTCT
GTACGC-3’ for I-II-III-myc; 5’- 
CCGGAAGTCTTACCCCTATGACGTCCCAGATTATGCATGATCCACACCTTCTG
TACGC-3’ for I-II-III-HA). N-glycosylation site (A2538N, V2540T) which is 
homologous to that produced in acetylcholinesterase [34] was added to Tg-CD and ChEL 
constructs using the following primer and its complement oligo (5’- 
GGACTCAGATGCCCGCATCCTTGCTAATGCTACATGGTATTACTCCTTGGAGC
ACTCC-3’). Each construct was confirmed by direct DNA sequencing before expressed 




Cell culture and transfection 
293 cells were cultured in DMEM with 10% fetal bovine serum in 6 well plates at 
37ºC in a humidified 5% CO2 incubator. Plasmids were transiently transfected using 
TransIT-LT1 or Lipofectamine 2000 transfection reagent according to the manufacturer’s 
instructions. 
 
Metabolic labeling and immunoprecipitation 
Transfected 293 cells were starved for 30 min in met/cys-free DMEM, then pulse 
labeled with 180 μCi/ml 
35
S-amino acids. The labeled cells were then washed with an 
excess of cold Met/Cys and chased in complete DMEM. At each time point, cells were 
lysed in buffer containing 1% NP-40, 0.1% SDS, 0.1 M NaCl, 2 mM EDTA, 25 mM Tris 
pH 7.4 and protease inhibitor cocktail cocktail (for cells expressing authentic 
acetylcholinesterase, lysis buffer contained 1% Triton X-100, 0.1 M NaCl, 2 mM EDTA, 
25mM Tris pH 7.4 and protease inhibitors). For immunoprecipitation, anti-Tg or anti-
acetylcholinesterase antibodies were incubated with samples overnight at 4ºC, and the 
immunoprecipitate was recovered with protein A- Agarose (for anti-Tg) or protein G-
Agarose (for anti-acetylcholinesterase). For co-immunoprecipitation studies, samples 
were incubated overnight at 4ºC with anti-myc antibodies and protein A-Agarose. 
Immunoprecipitates (or co-precipitates) were washed three times before boiling in SDS 
sample buffer with or without reducing agent, resolved by SDS-PAGE, and analyzed by 
fluorography or phosphorimaging. 
 
Endoglycosidase H digestion 
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Immunoprecipitates were boiled for 10 min in denaturing solution with 0.5% SDS 
(or, for Tg D2708C/G2709stop, omitting) containing 1% 2-mercaptoethanol and digested 




Use of epitope tagging to follow Tg transport and dimerization 
The use of sucrose-velocity gradient centrifugation has been a “gold standard” in 
examination of the homodimerization of wildtype endogenous Tg [35, 36]. However, for 
the study of dimerization properties of recombinantly expressed mouse Tg and its 
domains, we exploited bioengineering methods to tag discrete Tg subunits. Using a (0.5 h) 
pulse – (5 h) chase protocol, we established that wild-type Tg tagged at the carboxyl-
terminus with a green fluorescence protein (GFP) moiety was efficiently secreted, being 
converted from an endoglycosidase H-sensitive form (large mobility shift upon endo H 
digestion) to an endo H-resistant form (small mobility shift upon digestion) – precisely as 
seen for untagged Tg (Figure 3-1A). Adding a triple-myc (3xMyc) tag at the carboxyl-
terminus of wild-type Tg produced a similarly well-secreted protein whose release to the 
media could be blocked by inclusion of the rdw (G2298R) Tg mutation (Figure 3-1B). 
Co-expression of wild-type Tg-GFP with Tg-3xMyc offered one new means to examine 
Tg dimerization. When Tg-GFP was expressed in 293 cells in the presence or absence of 
co-expressed Tg-3xMyc, secreted Tg-GFP was positively recovered in the medium, as 
detected by Western blotting with anti-GFP antibody (Figure 3-1C right panel). If the 
medium was first immunoprecipitated with anti-myc antibody, then Tg-GFP expressed 
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by itself could no longer be recovered even though it had been secreted (i.e., anti-myc 
could not immunoprecipitate Tg-GFP, Figure 3-1C, left panel). By contrast, when co-
expressed, immunoprecipitation of the medium with anti-myc co-precipitated Tg-GFP 
(Figure 3-1C left). 
The identical media samples were also analyzed in reverse. Once again, when Tg-
3xMyc was expressed in the presence or absence of co-expressed Tg-GFP, secreted Tg-
3xMyc was positively recovered as detected by Western blotting with anti-myc (Figure 3-
1D right panel). If first immunoprecipitated with anti-GFP, then Tg-3xMyc expressed by 
itself could not be recovered, indicating that anti-GFP did not cross-react with Tg-3xMyc 
(Figure 3-1D, left panel). The anti-GFP antibody was less efficient for Tg-GFP 
immunoprecipitation (not shown). Nevertheless, to the extent that immunoprecipitation 
occurred, anti-GFP specifically co-precipitated wild-type Tg-3xMyc when co-expressed 
with wild-type Tg-GFP (Figure 3-1D left). Together, the data in Figure 3-1C and 1D 
provide strong evidence of dimerization between Tg subunits. 
 
Putative dimerization sequences in the Tg ChEL domain 
The carboxyl-terminal ChEL domain of Tg is comprised of 581 residues with 
distinct homology to acetylcholinesterase [10, 11], which undergoes homodimerization 
via formation of a 4-helix bundle that engages two helices from each monomer [32-34]. 
Using the PSI-PRED program for prediction of protein secondary structure [37], we 
examined the sequence of the Tg ChEL domain. We found sequences in the carboxyl-
terminal half of the ChEL domain predicted with high confidence to form helical 
segments (highlighted residues, Figure 3-2). Notably, these sequences are positioned 
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identically to those for the dimerization helices of acetylcholinesterase [32]. We thus 
hypothesized that Tg might use this carboxyl-terminal region to encode 
homodimerization necessary for intracellular protein transport. 
 
Engagement of the ChEL domain in Tg dimerization 
Evidence indicates that Tg with a dysfunctional ChEL domain cannot 
homodimerize [30]. To check possible homodimerization of regions I-II-III in the 
absence of ChEL, we engineered I-II-III-myc and I-II-III-HA tagged proteins. Either 
individually, or by co-transfection, both constructs were well expressed in 293 cells as 
detected by immnoblotting with anti-HA or anti-myc (Figure 3-1E left panel). Under co-
immunoprecipitation conditions, immunoprecipitation with anti-myc recovered the I-II-
III-myc protein; however, no co-immunoprecipitation of I-II-III-HA could be detected 
(Figure 3-1E right panel). Co-immunoprecipitation also could not be detected when the 
anti-HA antibody was employed for immunoprecipitation (not shown). These results (in 
contrast to those obtained for the isolated ChEL domain, see below) suggest that Tg I-II-
III – which is known to be defective in export from the ER [13, 29] – cannot 
homodimerize. By contrast, in the absence of I-II-III, secretory ChEL with a carboxyl-
terminal myc tag is efficiently secreted [13] and current evidence indicates that epitope 
tagging itself does not block Tg dimerization (Figure 3-1C, D). To examine the 
dimerization potential of secretory ChEL-myc with full-length wild-type Tg, the two 
proteins were co-expressed in 293 cells. With or without secretory ChEL-myc, full-length 
Tg was efficiently secreted as judged by anti-Tg immunoprecipitation (Figure 3-3 left 
panel). In addition, when co-expressed, full-length wild-type Tg could be co-precipitated 
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from the medium with secretory ChEL-myc (Figure 3-3). While the efficiency of this co-
precipitation was low (Figure 3-3, which suggests that for secretory ChEL to dimerize 
with Tg, it must compete against Tg homodimerization), the data (Figure 3-1E; Figure 3-
3) collectively suggest that the isolated ChEL domain is both necessary and sufficient for 
dimerization of Tg. 
Both authentic acetylcholinesterase and the Tg ChEL domain use their 6 Cys 
residues for intrachain disulfide bonding, while a unique additional Cys residue in 
authentic acetylcholinesterase (upward arrow Figure 3-3A) falls in a peptide extension at 
the extreme carboxyl-terminus of the monomeric protein just downstream from the ChEL 
homology region that includes one of dimerization helices [32, 34]. Crystallographic 
evidence indicates that this unpaired Cys residue can form an intersubunit disulfide bond, 
which covalently stabilizes acetylcholinesterase homodimers [38]; The presence of such a 
bond may be exploited as an assay of dimerization potential by nonreducing SDS-PAGE. 
In 293 cells pulse-labeled with 
35
S-amino acids and chased for 3 h, acetylcholinesterase 
was specifically immunoprecipitated from the chase medium bathing transfected cells, 
while only background bands were recovered from cells transfected with empty vector 
(Figure 3-4B). Unrelated to minor heterogeneity in N-linked glycosylation (data not 
shown), by nonreducing SDS-PAGE, secreted acetylcholinesterase could be recovered at 
two positions equivalent to monomer and dimer molecular masses (Figure 3-4B). 
Because dimerization of acetylcholinesterase does not require, nor uniformly employ, the 
optional intersubunit disulfide bond [39, 40], it is likely that all secreted 
acetylcholinesterase (Figure 3-4B) is homodimeric although only a portion is stabilized 
with the intersubunit disulfide bridge. 
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We wished to exploit this assay to examine dimerization potential of the Tg ChEL 
domain in the absence of co-expressed full-length wild-type Tg. With this in mind, we 
mutagenized secretory ChEL to introduce a cysteinyl residue at the carboxyl-terminus of 
mature murine Tg (Figure 3-4A downward arrow equivalent to D2708C,G2709stop 
mutation) immediately following the helical segment expected to participate in formation 
of the 4-helix bundle for dimerization. The construct was denoted as "ChEL-CD" to 
signify the intent to create a construct with “covalent dimerization” potential. With or 
without the CD mutation, secretory ChEL proteins exhibited efficient intracellular 
transport (Figure 3-4C), acquiring endoglycosidase H-resistance within a few hours of 
synthesis (not shown). However by nonreducing SDS-PAGE secretory ChEL-CD was 
recovered (in part) as a covalent homodimer (Figure 3-4C right). As each of the upstream 
6 Cys residues are engaged in evolutionarily conserved intrachain disulfide bonds and 
thus unavailable for interchain pairing, the acquisition of a new intersubunit covalent 
bond in ChEL-CD requires engagement of the new unique Cys residue from both 
monomeric partners, indicating tail-to-tail dimerization of the ChEL domain like that for 
acetylcholinesterase. 
To determine if full-length Tg also engages in tail-to-tail homodimerization, we 
examined Tg-CD in which the unpaired D2708C (Figure 3-4A) was incorporated into the 
larger Tg context (Figure 3-5). A D2708S mutant was also prepared as a negative control. 
First, 293 cells transfected to express Tg-CD were pulse-labeled with 
35
S-amino acids 
and chased for various times in the presence of brefeldin A (BFA) to block intracellular 
transport in the secretory pathway. Tg immunoprecipitates at each chase time were 
analyzed by nonreducing SDS-PAGE. At the zero chase time, as series of high molecular 
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weight intermediates termed "A, B, and C" (Figure 3-5A left) have been identified as Tg 
adducts with resident oxidoreductases of the ER lumen [41]. (These adducts appear as a 
smear when the cells are lysed in the absence of N-ethylmaleimide or similar aklyating 
treatment (Figure 3-5A) [13]). The "D" isoform (Figure 3-5A left) – which has been 
shown to be a partially oxidized Tg folding intermediate [13] – was also pronounced at 
the zero chase time. As reported for wild-type Tg [13], at 1 h of chase there was further 
maturation of monomers to the fully-oxidized “E” isoform (Figure 3-5A left). However, 
unlike for wild-type Tg, there was the new appearance of Tg-CD homodimers (Figure 3-
5A left panel). In cells in which secretion was blocked by BFA treatment, intracellular 
Tg-CD homodimers increased in intensity during the second chase hour (Figure 3-5A left 
panel). From BFA-treated cells, all of these isoforms of Tg migrated as a single band 
upon reducing SDS-PAGE (not shown). 
In the absence of BFA, it was clear that homodimerization of Tg-CD occurred 
intracellularly even before arrival in the Golgi complex, because a portion of the covalent 
Tg-CD homodimer had not yet acquired resistance to endoglycosidase H digestion 
(Figure 3-5A right). Such results are consistent with the long-held notion that Tg 
dimerization occurs in the ER and represents the last structural maturation step required 
for Tg export to the Golgi complex [14, 15]. Over time, increasing quantities of 
homodimeric Tg-CD were delivered to the medium (Figure 3-5A right). This 
accumulating amount was exclusively endoglycosidase H-resistant (not shown). 
It is known that neither authentic acetylcholinesterase (Figure 3-4B) nor 
endogenous Tg [41] require an intersubunit disulfide bond for dimer formation. To 
examine the relationship of the intersubunit disulfide bond of Tg-CD with its 
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dimerization, we employed sucrose velocity gradient centrifugation. Gradients were 
loaded from the top and finally collected from the bottom as previously described [41]. In 
the first three gradients shown in Figure 3-6, the secretion of endogenous Tg from PC Cl3 
thyrocytes was compared to that of recombinant wild-type Tg expressed in 293 cells. 
While 293 cells transfected with empty vector secreted no protein that could be 
immunoprecipitated with anti-Tg, 293 cells transfected to express wild-type mouse Tg 
secreted Tg protein that was recovered in the identical dimer fractions as those of the PC 
Cl3 standard; all running as the 330 kDa band by nonreducing SDS-PAGE. When 
transfected to express Tg-CD, 293 cells secreted species that ran at both the 660 kDa 
(covalent dimer) and 330 kDa monomer positions (Figure 3-6 right). Importantly, both 
bands were recovered exclusively in the dimer peak, demonstrating that Tg-CD has a 
fully preserved ability to homodimerize even without requiring the presence of the 
covalent intersubunit linkage. 
Altogether, the data strongly support that Tg-CD proceeds through the normal Tg 
folding pathway, achieving homodimerization (and normal intracellular transport), and 
within the context of the full Tg molecule the extra unpaired cysteine engineered at 
position 2708 engages in an interchain disulfide bond. We also found that Tg-
D2708S,G2709stop was secreted with equally high efficiency to that of wild-type Tg or 
Tg-CD, excluding any detrimental effects of the G2709stop codon, but this negative 
control exhibited no covalent dimerization (Figure 3-5B). Thus, given that secretory 
ChEL-CD (bearing the identical mutation) itself makes covalent homodimers (Figure 3-
4C), the accumulated evidence strongly indicates that tail-to-tail dimerization of Tg-CD 
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monomers creates a juxtaposition that allows the extra unpaired Cys residue of one 
monomer to partner with the identical Cys residue in the other monomer. 
 
Perturbation of dimer stability, and suppression of that perturbation 
Previous studies have suggested that introduction of an N-linked glycosylation 
site into the "α-7/8" helix of authentic acetylcholinesterase can decrease stability of the 4-
helix bundle for dimerization [34]. The predicted comparable helix in the ChEL domain 
of Tg is highlighted in Figure 3-2. Therefore, using a secretory ChEL-myc cDNA 
template, the A-A-V sequence shown in Figure 3-2 was mutagenized to N-A-T within the 
helical region (this mutant termed "ChELG-myc" to indicate our intent to create a new N-
linked glycosylation site). First, a double-epitope tag strategy was employed similar to 
that used successfully for full-length Tg (Figure 3-1). Specifically, secretory ChEL 
tagged with a carboxyl-terminal HA epitope was co-expressed in 293 cells either with 
secretory ChEL-myc or secretory ChELG-myc. Interestingly, using these constructs, both 
ChEL-myc and ChELG-myc were well secreted along with ChEL-HA. Anti-myc 
immunoprecipitation from media was specific and comparably efficient for myc-tagged 
secretory ChEL or ChELG, but the mobility of the ChELG protein was slower (Figure 3-
7A upper panel). [Deglycosylation experiments (not shown) confirmed that the 
engineered ChELG glycosylation site was utilized.] Interestingly, in comparison to 
ChEL-myc, ChELG-myc was deficient for co-precipitation of ChEL-HA (Figure 3-7A 
lower panel). 
We next engineered the same N-linked glycosylation site into the covalent 
dimerizing ChEL-CD construct (Figure 3-4C) to create ChELG-CD. Based on band 
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mobility, the glycosylation site was indeed utilized in all copies of ChELG-CD as it was 
for ChELG (Figure 3-7B reducing conditions). However, unlike ChEL-CD (Figure 3-4C), 
when all ChEL was glycosylated, covalent dimerization could no longer be detected by 
nonreducing SDS-PAGE (Figure 3-7B right). Together, the data in Figure 3-7 support 
that introduction of an N-glycan into one helix of the presumptive 4-helix bundle, 
decreases stability of dimerization of the ChEL domain of Tg. 
We noted that the fraction of secretory ChEL-CD that undergoes formation of the 
optional intersubunit covalent bond (Figure 3-4C) is a lesser fraction than that observed 
for full-length Tg-CD (Figure 3-5A). This suggested the intriguing possibility that 
additional information provided by upstream Tg regions I-II-III might improve tail-to-tail 
dimer alignment or stability. Indeed, ChEL exhibits direct physical interactions with I-II-
III [13]. To examine the role of I-II-III in the stabilizing homodimers, we expressed the 
ChELG-CD construct with or without co-expression of Tg regions I-II-III. As before 
(Figure 3-4C), covalent homodimers of ChEL-CD could be recovered without assistance 
from other Tg domains (Figure 3-8A, last lane). And as before (Figure 3-7B), the 
glycosylated ChELG-CD, expressed by itself exhibited diminished dimer stability as 
measured by a diminished ability to form the intersubunit covalent bond (Figure 3-8A, 
second lane). However, upon co-expression of I-II-III, which was co-secreted with 
ChELG-CD, the carboxyl-terminal intersubunit disulfide bond was restored between 
ChELG-CD homodimers (Figure 3-8A, third lane). The data indicate that in trans, Tg 
regions I-II-III provide added stability to the homodimerization of the Tg ChEL domain. 
To explore the significance of these findings, we introduced the same helix 
glycosylation site within the context of full-length Tg-CD. As expected, TgG-CD utilized 
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the additional glycosylation site (seen as a slower Tg monomer mobility by SDS-PAGE, 
Figure 3-8B). While the Tg-CD control was rapidly secreted with approximately two-
thirds of the protein containing the covalent intersubunit bond, TgG-CD was nearly as 
rapidly secreted and the ratio of covalent to noncovalent dimer was only modestly 
inhibited (Figure 3-7B). Altogether, the data indicate that while the ChEL domain is 
necessary and sufficient for Tg dimerization, upstream Tg regions I-II-III, either in cis or 
in trans, assist in Tg dimer stability. 
 
Discussion 
Tg transport through the secretory pathway is essential to make Tg available for 
iodination in the process of thyroid hormone biosynthesis. The structural features in Tg 
required for its intracellular transport are beginning to be elucidated. For one thing, the 
Tg ChEL domain must make physical contact with upstream regions I-II-III in a manner 
not requiring that ChEL be contained within the contiguous Tg polypeptide [13]. For 
another, Tg homodimerization is required for export from the ER [14, 15]. In this report, 
we show that secretory ChEL and Tg are both homodimeric proteins (Figure 3-1, Figure 
3-4 to Figure 3-8) that share predicted alpha helical sequences that closely align with the 
helices critical for homodimerization of acetylcholinesterase (Figure 3-2). Moreover, the 
isolated ChEL domain can cross-dimerize with intact Tg (Figure 3-3), suggesting that the 
ChEL domain encodes the minimal information necessary for Tg dimerization. To be 
effective, these sequences do not need to reside at the extreme C-terminus of Tg because 
introduction of downstream GFP, myc, or HA tags still allows dimerization via the ChEL 
domain to take place (Figure 3-1, Figure 3-3, Figure 3-7A). While the form of GFP we 
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employed may have oligomerization potential [42], the fact that Tg-GFP cross-dimerized 
with Tg-3xMyc indicates that dimerization was triggered by Tg sequences rather than by 
tag sequences. 
For acetylcholinesterase, homodimers brought together via a 4-helix bundle [32] 
may be further stabilized by an intermolecular disulfide bond engaging one unpaired 
cysteine that follows shortly after the carboxyl-terminal helical domain of each monomer 
(Figure 3-4A). Introduction of an unpaired Cys residue immediately after the predicted 
carboxyl-terminal helical sequence in the ChEL domain also allows for covalent bonding 
of secretory ChEL-CD homodimers (Figure 3-4C) and full-length Tg-CD (Figure 3-5). 
The simplicity of the one-dimensional nonreducing SDS-PAGE assay of Tg-CD 
dimerization makes pulse-chase experiments especially convenient. With this approach, 
Tg dimerization can clearly be shown to occur before acquisition of endoglycosidase H-
resistance, and also in cells in which intracellular transport is blocked by BFA treatment 
(Figure 3-5A). The data are consistent with our longstanding hypothesis that Tg 
dimerization occurs before export from the ER [14, 15] and that dimerization increases 
the efficiency of intracellular Tg transport [41]. With or without the intersubunit disulfide 
bond, Tg-CD has fully preserved dimerization (Figure 3-6) and exportability (Figure 3-
8B), but the covalent intersubunit linkage presumably reflects the stability of the dimer, 
which yields proper tail-to-tail alignment of the monomer polypeptides. 
Although structural biology studies of the Tg ChEL domain have not yet begun, 
based on the foregoing results we propose that the predicted alpha-helical segments 
within the ChEL domain of Tg are engaged in forming the contact zone essential to the 
dimer interface. To weaken this putative contact, we introduced a mutation converting the 
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A-A-V sequence of the first alpha helix (Figure 3-2) to an N-A-T glycosylation acceptor 
site. Presence of the ChELG mutation in one of the two subunits significantly decreased 
co-immunoprecipitation efficiency between the dimerization partners (Figure 3-7A), 
while presence of the same mutation in all copies of ChELG–CD completely eliminated 
the intersubunit disulfide bond (Figure 3-7B). While these data support a dimerization 
mechanism involving helical interactions similar to that for acetylcholinesterase, there are 
reasons to think that Tg homodimer stability rests on more than merely the four-helix 
bundle. First, the fraction of Tg-CD that makes an intersubunit disulfide bond (Figure 3-
5A) is higher than the fraction of secretory ChEL-CD making the same bond (Figure 3-
4C). Second, although Tg region I-II-III itself cannot dimerize (Figure 3-1E), when 
ChELG–CD is co-expressed with I-II-III, not only is I-II-III secretion rescued, but the 
intersubunit disulfide bond is once again established between ChEL partners (Figure 3-
8A). Thus in trans, I-II-III contributes to the dimer stability of ChELG. Third, mutation 
to add the same glycosylation site in full-length TgG-CD does not block efficient Tg 
secretion (that depends on dimerization [14, 15]) and only slightly decreases the fraction 
of TgG–CD making the intersubunit disulfide link (Figure 3-8B). Altogether, the 
evidence points to a reciprocal relationship, i.e., even as the ChEL domain functions as an 
intramolecular chaperone and escort for Tg regions I-II-III [13], I-II-III also assists in the 
stability of homodimerization of the ChEL domain. 
Multiple small Tg mutations causing congenital hypothyroidism have been 
identified within the ChEL domain ([19, 20, 27, 28] with others reviewed in [23]). Both 
defective intramolecular chaperone function [13] and defective Tg dimerization [30] are 
an expected consequence of such mutations. Additionally, it seems likely that many 
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additional mutations in Tg regions I-II-III may fail to provide adequate homodimer 
stability, which could account for why many if not all cases of hypothyroidism with 
mutant Tg derive from a failure of intracellular transport through the secretory pathway 
[25]. Conversely, the present studies provide reason to believe that some of these mutants 
might not be totally dysfunctional, with some Tg ChEL domain mutations perhaps being 
intramolecularly suppressed in part by upstream Tg domains (Figure 3-8B) while other I-
II-III mutations might still be able to heterodimerize with full-length Tg (Figure 3-3). In 
summary, intracellular Tg transport for thyroid hormone synthesis engages the ChEL 
domain not only as an intramolecular chaperone and escort [13], but herein we show that 
ChEL is also a nidus for Tg homodimerization. While the ChEL domain is both 
necessary and sufficient for Tg transport through the secretory pathway, ChEL 
interactions with upstream Tg regions stabilize the homodimer. Structural studies will be 
needed to elaborate the contact sites between monomeric subunits, while additional 
molecular dissection is needed to identify the site(s) in ChEL that functionally interact 
with I-II-III and the site(s) in I-II-III that functionally interact with ChEL. 
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Figure 3-1. Association of epitope-tagged thyroglobulins. 293 cells were either 
untransfected (also called Control), transfected with one epitope-tagged construct, or co-
transfected. (A) Cells untransfected or transfected with the constructs shown were pulse-
labeled for 30 min with 
35
S-amino acids and chased for 5 h. Both cells (C) and media (M) 
were immunoprecipitated with anti-Tg, divided in two equal portions, and either mock-
digested ("-") or digested ("+") with endoglycosidase H (Endo H). Tg remaining in the 
cells was primarily endo H-sensitive. Tg secreted to the medium had a slightly slower 
mobility, and acquired endo H-resistance (although a portion of the glycans on each Tg 
molecule remain permanently sensitive to endo H). Tg-GFP migrated more slowly than 
untagged Tg but otherwise exhibited the same pattern. (B) Cells untransfected or 
transfected with the constructs shown were pulse-labeled for 30 min with 
35
S-amino acids 
and chased for 4 h. Both cells and media were immunoprecipitated with anti-Tg. Tg-
3xMyc was efficiently secreted whereas the same construct bearing the rdw mutation was 
blocked intracellularly. (C) 293 cells were transfected with the constructs shown and 
media collected for 24 h. Each sample was divided and analyzed by SDS-PAGE, 
electrotransfer and immunoblotting with anti-GFP antibody either without (right half of 
gel) or after immunoprecipitation (IP, left half of gel) with anti-myc antibody. Note that 
no Tg-GFP is directly immnoprecipitated with anti-myc, whereas Tg-GFP is co-
immunoprecipitated when coexpressed with Tg-3xMyc. (D) Cells transfected and media 
collected as in C were analyzed by SDS-PAGE, electrotransfer and immunoblotting with 
anti-myc either without (right half of gel) or after immunoprecipitation (IP, left half of 
gel) with anti-GFP. As before, Tg-3xMyc is coprecipitated with Tg-GFP. (E) 293 cells 
were transfected with I-II-III-myc, I-II-III-HA, both, or neither, and the cells were lysed 
at 48 h in buffer containing 1% NP40 and no SDS. Each sample was divided and 
analyzed by SDS-PAGE, electrotransfer and immunoblotting with anti-HA (upper panels) 
and anti-myc (lower panels) either without (left panels) or after immunoprecipitation (IP, 
right panels) with anti-myc. While I-II-III-myc is readily immunoprecipitated, no co-




Figure 3-2. Sequence of the ChEL domain of mouse Tg. The 581 residue domain 
extends from residues 2166 to the carboxyl-terminal residue 2746. Based on secondary 
structural prediction, two alpha-helical segments (highlighted) are predicted to match 
what is referred to as the α-7/8 helix and α-10 of acetylcholinesterase [32, 34]. Residues 
that are bolded and underlined indicate sites that have been mutagenized. Replacement of 
the A-A-V sequence with an N-A-T sequence introduced an N-linked glycosylation 
acceptor site within the α-7/8 helical homology sequence, and the D2708C,G2709stop 
mutation introduced just downstream of the α-10 helical homology sequence was created 





Figure 3-3. Heterodimerization of the ChEL domain with Tg. 293 cells were either 
untransfected or transiently transfected to express wild-type Tg (wt Tg) or that plus 
secretory ChEL bearing a carboxyl-terminal myc epitope tag (ChEL-myc). Cells were 
pulse-labeled for 30 min with 
35
S-amino acids and chased for 5 h, and media were 
immunoprecipitated with either anti-Tg (which recovers both proteins, left panel) or anti-
myc (right panel) before SDS-PAGE and fluorography (which, after anti-myc 
immunoprecipitation, was overexposed ~2-fold). The secretory ChEL-myc protein by 
itself is known to be rapidly secreted [13]. Immunoprecipitation with anti-myc recovered 
a fraction of secreted Tg only when co-expressed with secretory ChEL-myc, indicating 







Figure 3-4. The ChEL domain and authentic acetylcholinesterase (AChE) share 
capabilities in protein dimerization. (A) Primary sequence alignment at the carboxyl-
terminal end of acetylcholinesterase, indicating a nonhomologous peptide extension that 
bears an extra, unpaired cysteine (upward arrow) immediately following the α-10 helix 
that is engaged in homodimerization of acetylcholinesterase. Mouse Tg engineered to 
terminate with an extra, unpaired cysteine at residue 2,708 (Tg-D2708C,G2709stop  = 
"TgCD") is shown with a downward arrow on the primary sequence. (B) 293 cells 
transiently transfected to express human acetylcholinesterase (hAChE) or empty vector 
were labeled with 
35
S-amino acids for 2 h and chased further for 3 h in complete medium 
before immunoprecipitation of acetylcholinesterase from cell lysate (C) and medium (M) 
with analysis by nonreducing SDS 8%-PAGE and fluorography. (All bands recovered 
from cells bearing empty vector represent nonspecific background.) (C) 293 cells were 
either untransfected controls (C) or transiently transfected to express secretory ChEL 
("wt", a prolactin signal peptide preceding the ChEL domain of wild-type mouse Tg) or 
secretory ChEL-CD ("CD"). Cells were pulse-labeled for 30 min with 
35
S-amino acids 
and chased for 4 h, at which time the cell lysates and media immunoprecipitated with a 
rabbit polyclonal anti-Tg. Immunoprecipitates were analyzed by SDS-PAGE under 
reducing or nonreducing conditions, as indicated. The positions of covalent ChEL-CD 
dimer and noncovalent dimer (which runs as monomer by SDS-PAGE) are shown. The 





Figure 3-5. Covalent assembly of Tg-CD indicates tail-to-tail engagement of Tg 
homodimers. (A) 293 cells were either mock-transfected (Trnfx'n "-" as indicated at 
bottom) or transiently transfected with a vector encoding a "Tg-CD" construct containing 
D2708C,G2709stop. Left panel: Cells were pulse-labeled for 30 min with 
35
S-amino 
acids and chased in the presence of brefeldin A (BFA, 5 μg/mL) for the times indicated. 
Cell lysates were immunoprecipitated with anti-Tg and analyzed by nonreducing SDS 
4%-PAGE and fluorography. A smear of high molecular weight bands corresponding to 
those previously reported to represent Tg adducts with ER oxidoreductases [41] is termed 
"A, B, and C". A newly-described Tg oxidative folding intermediate "D" [13] is also 
shown. The positions of covalent Tg-CD dimer and noncovalent dimer (which runs with 
mature Tg monomer form "E") are shown. Right panel: The same experiment but without 
BFA, in which both cell lysates and chase media were collected at 1 h and 2 h of chase. 
Immunoprecipitated Tg from each cell lysate was divided into equal portions and either 
mock-digested or digested with endoglycosidase H before non-reducing SDS-PAGE and 
fluorography. Intracellular bands near the Tg-CD monomer position are mostly endo H-
sensitive (but also include some endo H-resistant Tg-CD that had not made an 
intersubunit disulfide bond). The intracellular covalent dimers are subdivided into two 
components: a faster-migrating endo H-sensitive population (indicating dimerization 
before transport into the Golgi complex) and a slower-migrating population of endo H-
resistant Tg-CD. In the media, exclusively the slower-migrating covalent Tg-CD dimer 
(as well as noncovalent dimer, which runs as monomer) is recovered. (B) As a control for 
the Tg-CD mutation, a D2708S,G2709stop mutant was efficiently secreted but none of 





Figure 3-6. Dimerization of secreted Tg as measured by sucrose velocity gradient 
centrifugation. First gradient: Endogenous Tg secreted by the metabolically-labeled PC 
Cl3 thyrocyte cell line. All gradient fractions (collected from the bottom) were 
immunoprecipitated with anti-Tg antibodies and analyzed by nonreducing SDS-PAGE. 
The positions of the monomer (MON) and dimer (DIM) peaks are indicated below. 
Second gradient: Media from metabolically-labeled 293 cells transfected with empty 
vector were immunoprecipitated with anti-Tg and analyzed identically. Third gradient: 
Media from metabolically-labeled 293 cells transfected to express wild-type mouse Tg 
(wt Tg) were immunoprecipitated with anti-Tg and analyzed identically. Note that all 
recombinant Tg is secreted in the dimer peak. Fourth gradient: Media from 
metabolically-labeled 293 cells transfected to express Tg-CD were immunoprecipitated 
with anti-Tg and analyzed identically. Note that all Tg-CD is secreted in the dimer peak, 
although a portion of these dimers lack the intersubunit disulfide bond. (Sucrose gradient 





Figure 3-7. Perturbing ChEL dimer stability by introduction of an N-linked 
glycosylation site into the α-7/8 helical sequence (Figure 3-2) found to perturb 
subunit contact in acetylcholinesterase [34]. The A-A-V to N-A-T mutagenesis to 
create an N-linked glycosylation site is highlighted in Figure 3-2. (A) 293 cells were 
either untransfected or transiently transfected to express either secretory ChEL-myc or 
that bearing the extra glycosylation site (ChELG-myc) in conjunction with an equal 
amount of plasmid DNA encoding secretory ChEL-HA. Cells expressing ChEL-HA 
alone were included as negative control. Secretion media were collected for 24 h and 
immunoprecipitated with anti-myc before SDS-PAGE. Immunoprecipitates were then 
Western blotted (WB) with either anti-myc (upper panel, to demonstrate recovery of 
ChEL-myc or ChELG-myc) or anti-HA (lower panel, to examine the extent of co-
precipitation of the dimerization partner). Introduction of an N-glycan slows the mobility 
of the ChEL-myc band (upper panel) and decreases the co-precipitation of ChEL-HA 
(lower panel). (B) The ChELG mutation was introduced into secretory ChEL or secretory 
ChEL-CD and these constructs were transiently expressed in 293 cells. Secretory ChEL 
and secretory ChELG (lacking potential for covalent intersubunit bonding) were included 
as controls for SDS-PAGE mobility. The cells were metabolically labeled and chased for 
4 h; the media were immunoprecipitated with anti-Tg and analyzed by SDS 4%-PAGE 
under reducing and nonreducing conditions. Note that when ChELG-CD is the sole 






Figure 3-8. Effect of Tg regions I-II-III on the dimer stability of glycosyated ChELG 
domain. (A) 293 cells were transiently transfected either with the secretory ChELG-CD 
construct alone or cotransfected in the presence of Tg I-II-III. The covalent dimerizing 
ChEL-CD construct was analyzed in parallel, as a control. Cells were pulse-labeled for 
20 min with 
35
S-amino acids and chased for 4 h; media was collected and 
immunoprecipitated with anti-Tg, followed by nonreducing SDS 5.5%-PAGE and 
fluorography. While secretory ChELG-CD alone produced no covalent homodimer, 
inclusion of Tg I-II-III increased ChELG-CD secretion with covalent dimerization similar 
to that of the control, secretory ChEL-CD. (B) 293 cells were transiently transfected to 
express full-length Tg-CD or TgG-CD bearing the extra N-linked glycosylation site in the 
ChEL domain. Cells were pulse-labeled for 30 min with 
35
S-amino acids and chased for 6 
h before analysis by Tg immunoprecipitation and nonreducing SDS 4%-PAGE and 
fluorography. Based on mobility of the TgG-CD band, the extra glycosylation site is 
clearly used; nevertheless, covalent intersubunit interaction proceeds with only a small 
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DISCUSSION AND FUTURE DIRECTIONS 
 
The functional and structural importance of thyroglobulin (Tg), which has 
evolved as a precursor for thyroid hormone synthesis, has begun to emerge after years of 
biochemical and cell biological studies. It is interesting to consider the complexity of 
thyroid hormonogenesis, i.e., how many players are involved to make, deliver, and 
activate thyroid hormone. The thyroid gland, the sole source of thyroid hormone 
production, requires multiple reactions; 1) iodide transfer by a series of iodide 
transporters, 2) iodide storage and thyroid hormone synthesis within the Tg molecule, 
which requires Tg secretion, iodination, and coupling reaction to produce iodothyronines, 
and 3) endocytosis and proteolysis of Tg to release thyroid hormone to the blood stream. 
Tg has some unique features including its large size (330 kDa, monomer) that 
proceeds to homodimerize (660 kDa). Tg consists of ~2,750 amino acid residues (for 
monomer) although thyroid hormone is made by conjugation of only two di-iodinated 
tyrosyl residues. The major hormonogenic site in Tg is limited to the N-terminus of the 
molecule (Tyr5 – Tyr130). Tg is not an enzyme nor a re-usable molecule, therefore the 
thyroid gland makes this large protein in order to produce only a couple of thyroid 
hormones per Tg molecule. Additionally, iodination for the purpose of thyroid hormone 
formation occurs at the apical surface outside of thyroid cells, with massive storage of 
93 
 
iodinated Tg in the follicular space of thyroid glands. Therefore, production of thyroid 
hormone is totally dependent upon Tg delivery via the secretory pathway. 
I have considered the possibility that the C-terminal region of Tg may serve a 
primary function to assist in Tg folding and intracellular transport. Previously, mutations 
in the ChEL domain of Tg (cog and rdw) have been described to cause hypothyroidism 
by preventing secretion of Tg [1, 2]. Further, the Tg N-terminal region (I-II-III) expressed 
without the ChEL domain was reported to fail in secretion [3]. These findings lend 
support to the thesis that ChEL assists in the intracellular protein transport of Tg by 
facilitating the formation of a proper native structure of Tg involving reciprocal 
interactions between ChEL and upstream regions of Tg. 
 
The ChEL domain functions as an intramolecular chaperone and escort for Tg 
folding and secretion 
Tg primary structure consists of many repeating units. The exon-intron 
boundaries and the striking homology of Tg-type 1 repeats, as well as that of the ChEL 
domain, suggests that Tg structure has evolved by duplication of genes. Domains 
translated by duplicated genes are generally believed to keep their native structures, and 
there are reasons to expect that each unit in Tg has its own internal structure (and 
performs its own folding). The independently folding domains of Tg are expected to start 
their folding co-translationally with the help of ER chaperones [4, 5]. In GA733-2 
(human gastrointestinal carcinoma antigen) and other proteins that contain homologous 
type 1 Tg repeats, cysteines form consecutive intrachain disulfide bonds within the 
homologous region [6]. These cysteines are highly conserved and believed to function in 
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maintaining the compact structure of type 1 repeat-containing proteins. N-terminal 
fragments of Tg that contain the first three type 1 repeat units can pass ER quality control 
and be secreted from cells [7]. The ChEL domain also has six conserved cysteines that 
are important to the native structure of acetylcholinesterase family members (Figure 1-3). 
Other amino acid residues comprising the backbone structure of acetylcholinesterase are 
well preserved in the ChEL domain of Tg (Figure 1-4A). All evidence indicates that 
ChEL forms an independently folded domain within Tg, because its replacement by 
authentic acetylcholinesterase results in a chimera with active cholinesterase function [3]. 
Moreover, the ChEL domain (led by a signal peptide) rapidly and efficiently exits the ER 
and is secreted (Figure 2-4). Regions II-III with its own signal peptide also are well 
secreted (Figure 4-1B), indicating that these two regions can also fold as a successful unit, 
suggesting these two regions are unlikely to require assistance from ChEL. 
Instead of a linear, string-like structure, Tg is thought to have an oval-like native 
structure [8]. From this, it is certainly reasonable to hypothesize that some Tg domains 
may get help from interaction with other domains in order to facilitate folding. Limited 
proteolysis of Tg also provides clues to solvent-exposed regions versus other regions that 
are likely to be buried [9, 10]. Understanding the three dimensional structure of Tg could 
help to explain the epitopes that may help to trigger autoimmune thyroiditis [11].  
Final formation of native Tg structure occurs post-translationally. Tg uses most of 
its 122 cysteines in disulfide pairings. Interchain disulfide bonding has not been 
described in newly secreted Tg. Therefore, most cysteines form intrachain disulfide 
bonds (a maximum of 61-intrachain disulfide bonds is possible). The domain structure of 
Tg readily accounts for most of these. New assays were derived to examine post-
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translational maturation of Tg as described in chapters 2 and 3. In order to follow the 
folding progress of Tg, I used a pulse-chase paradigm and analyzed results by 
nonreducing SDS-PAGE [4]. For secretory proteins, disulfide maturation has been 
described as a rate-limiting step in folding process within the ER [12]. Therefore, Tg 
requires post-translational time to form all of its disulfide bonds, and proper formation of 
these bonds is tightly correlated with folding progress. 
Immediately after its translation, Tg has not yet reached its fully mature form 
(known as “E”) by nonreducing SDS-PAGE (Figure 2-3). Instead, nascent Tg is in 
complexes with ER oxidoreductases forming bands “A, B, and C” [4] as well as the 
immature monomer known as “D” (Figure 2-3). In general, only after Tg takes additional 
conformational maturation steps to the “E” form and also takes steps to form homodimers 
(chapter 3) can it then be secreted from cells (Figures 2-3 and 3-5). 
In chapter 2, one of the hypothesis tested is that global maturation of Tg requires 
the ChEL domain as an intramolecular chaperone. One possible reason for the ER 
retention of cog Tg and rdw Tg is the failure of disulfide maturation from “D” to “E” 
forms as shown in Figure 2-2C. By contrast, wild-type Tg always progresses to the “E” 
form prior to its secretion. Misfolding of the ChEL domain caused by cog or rdw 
mutation might affect global folding as evidenced by its remarkable reactivity with AMS 
(Figure 2-1). The influence of the ChEL domain on upstream regions of Tg is further 
supported by the fact that Tg regions I-II-III alone are incompetent for secretion [3], 
while that secretion can be rescued by secretory ChEL provided in trans (Figure 2-5C). 
Although Tg regions I-II-III repeat domains are expected to fold independently, they may 
still need further structural arrangement that depends on the ChEL domain. By 
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nonreducing SDS-PAGE, I-II-III alone shows unsuccessful progression of its disulfide 
maturation (Figure 2-8A), persisting as a “D”-like form. This is similar to the arrested 
progression of full-length Tg bearing mutations in the ChEL domain. Indeed, secretory 
ChEL in trans physically interacts with upstream regions of Tg (Figure 2-6A) and allows 
I-II-III to progress in disulfide maturation, reaching an “E”-like form (Figure 2-8A). A 
technical point is that the best nonreducing SDS-PAGE analysis requires removal of 
sugars by PNGase F (Figure 2-9). 
More than 70% of eukaryotic proteins are multidomain proteins [13]. Proteins 
(domains) are expected to assume their native structure by virtue of their own 
thermodynamic stabilities [14]. However, cooperative interaction among domains and co-
dependency for efficient folding have been described [13, 15]. In this thesis research, I 
propose that Tg is another example in which interdomain interaction is required for 
efficient Tg folding and it is mediated by the C-terminal ChEL domain acting as an 
intramolecular chaperone. 
Curiously, the ChEL domain has an even stronger affinity for well-folded I-II-III 
than it does for immature I-II-III (Figure 2-10). This binding seems essential for the Tg 
secretory process. Secretory ChEL with an engineered ER-retention motif functions 
normally as a molecular chaperone (Figure 2-8) yet co-retains the mature I-II-III within 
the ER-Golgi system (Figure 2-11). Thus, the ChEL domain also functions as a molecular 
escort [16] required to convey Tg I-II-III out of the ER. 
The intramolecular chaperone and escort functions of the ChEL domain are 
specific and dependent upon structural features of the ChEL domain. Misfolding 
mutations in secretory ChEL such as cog or rdw prevent upstream regions of Tg (I-II-III) 
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to progress through the normal stages of disulfide bond maturation (Figure 2-8B) or to be 
secreted (Figure 2-11B) even though they can physically interact with regions I-II-III (not 
shown). Moreover, authentic acetylcholinesterase cannot substitute for the ChEL domain 
even though it is similar to ChEL in structure. The chimeric protein of Tg in which 
regions I-II-III connect contiguously with human acetylcholinesterase cannot be secreted 
even though I can confirm that acetylcholinesterase in the chimeric protein has proper 
folding based on its enzymatic activity (not shown). Acetylcholinesterase can bind 
physically with Tg regions I-II-III, but it fails to rescue of secretion of I-II-III (not shown) 
which contradicts a previous report [3]. Disulfide maturation to the “E” form has not 
been observed in Tg-acetylcholinesterase chimeras, or in the isolated Tg regions I-II-III 
when acetylcholinesterase is expressed in trans (Wang, X., unpublished data). 
In summary of chapter 2, I propose that Tg structural maturations and intracellular 
transport for thyroid hormone synthesis are dependent on intramolecular chaperone and 
escort functions embedded within the Tg ChEL domain. 
 
The ChEL domain and Tg dimerization 
After formation of a compact Tg monomer, Tg proceeds to homodimerization 
which is required for export from the ER [17, 18]. It is notable that of the established 
members of the cholinesterase-like family of proteins, acetylcholinesterase and 
neuroligins are known to form homodimers using the same contact zone involving a four-
helix bundle (Figure 1-4B) [19-23]. Evidence suggests that dimerization via this 
conserved mechanism is essential for the diverse functions of these proteins [24, 25]. In 
chapter 3, I showed that secretory ChEL and Tg are also both homodimeric proteins 
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(Figures 3-1, 3-4 to 3-8) sharing predicted alpha helical sequences that closely align with 
the helices critical for homodimerization of acetylcholinesterase and neuroligins (Figure 
3-2). 
For acetylcholinesterase, homodimers through the four-helix bundle may be 
further stabilized by an intermolecular disulfide bridge engaging one unpaired cysteine 
that follows shortly after the carboxyl-terminal helical domain of each monomer (Figure 
3-4A). This allowed me to assay dimerization by formation of a double molecular mass 
band mobility upon nonreducing SDS-PAGE. Introduction of an unpaired Cys residue 
immediately after the predicted carboxyl-terminal helical sequence in the ChEL domain 
allowed for covalent bonding of secretory ChEL-CD homodimers (Figure 3-4C) and full-
length Tg-CD (Figure 3-5). The formation of interchain disulfide bonds in secretory 
ChEL-CD and Tg-CD specifically indicates the formation of a four-helix bundle because 
none of the cysteines in secretory ChEL (6 Cys residues) forms an interchain disulfide 
bond as they are each already engaged in one of the three evolutionarily conserved 
intrachain disulfide bonds. The interchain disulfide made by full-length Tg-CD 
undoubtedly uses the same Cys residues as the extra cysteine embedded in the ChEL 
domain. Therefore, ChEL preserves its evolutionarily conserved dimerization, and Tg 
uses this to stabilize the Tg homodimer. Further, introduction of glycosylation site into 
one of the predicted helices for dimerization of secretory ChEL (ChELG or ChELG-CD) 
decreased the ability of such a protein to interact with the wild-type partner (Figure 3-7A) 
and completely eliminated the intersubunit disulfide bond in ChELG-CD (Figure 3-7B). 
Using a combination of methodologies including pulse-chase analysis in 
conjugation with nonreducing SDS-PAGE, I observed that Tg dimerization appears 
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immediately after full maturation of Tg monomers (“E” form) and occurs early, before 
Golgi arrival (Fig 3-5A). These data are consistent with previous studies of thyroid cells, 
and support the longstanding hypothesis that Tg dimerization occurs before export from 
the ER [17, 18]. 
I have been unable to detect any dimeric interaction between regions I-II-III 
lacking the ChEL domain (Figure 3-1E), whereas the isolated ChEL domain can cross-
dimerize with intact Tg (Figure 3-3). These data suggest that the ChEL domain encodes 
the minimal information necessary for Tg dimerization. However, Tg homodimer 
stability appears to depend on more than the four-helix bundle within the ChEL domain, 
because the presence of I-II-III enhanced the formation of the interchain disulfide bond in 
ChEL-CD (Figures 3-4C and 3-5A) and overcame the inhibitory effect of the 
glycosylation mutation on ChEL-CD dimerization, either in cis or in trans (Figures 3-8). 
Altogether, the evidence points to an interesting reciprocal structural relationship, i.e., the 
ChEL domain functions as an intramolecular chaperone for Tg regions I-II-III (chapter 2, 
[26]) while I-II-III assists in the ChEL domain homodimer stability (chapter 3). 
In summary, intracellular Tg transport for thyroid hormone synthesis engages 
structural maturation of Tg in which the ChEL domain not only functions as an 
intramolecular chaperone for monomer folding (chapter 2, [26]), but also as a nidus for 
Tg homodimerization (chapter 3) and an escort that conveys I-II-III out of the ER 
(chapter 2). The quaternary structure of Tg requires reciprocal interaction between 
upstream regions of Tg and the ChEL domain facilitating I-II-III folding and stabilizing 




It is interesting to consider the evolutionary dependence of Tg on the C-terminal 
ChEL domain, given that the major hormonogenic site of Tg is at its extreme N-terminus 
[27]. It might be expected that a highly truncated Tg with the N-terminal thyroid 
hormone-forming site [28, 29] would allow hormone production without the need for 
intramolecular chaperone or escort functions. Indeed, an N-terminal portion of Tg with 
hormonogenic tyrosines can be secreted [7] and thyroid hormones (T4 and T3) can 
theoretically be produced from such a truncated Tg [30]. However, an N-terminal 
fragment of Tg is not enough to allow animals to survive in an environment with low 
iodine availability [31]. Therefore, environmental circumstances (such as low iodide 
availability in freshwater and on land) might have applied evolutionary pressure for 
development of a more complex Tg molecule capable of iodide storage in vertebrate 
organisms [32]. It is also consistent with the notion that an early ancestor of land 
dwelling animals may have been fish designed to live in freshwater in which iodide is 
lacking. Modern fish have similar sized Tg-like iodoproteins [33, 34] (note the comment 
on zebrafish Tg in chapter 1). 
Bigger proteins such as Tg may face greater problems of misfolding and protein 
aggregation. Tg may have adopted the ChEL domain in order to minimize misfolding and 
enable intracellular transport. Among the reported inactivating mutations of Tg (Table 1-
1), many are reported to cause a mild disease phenotype [7, 35]. The R19K mutation 
causes misfolding in the first type 1 repeat and almost completely prevents secretion of 
an N-terminal fragment of Tg (C175stop). However full Tg with R19K shows only midly 
impaired secretion [7], consistent with the less severe phenotype of Tg-R19K in patients. 
Another mutation, Tg-C1977S (C1976S in mouse Tg) causes mild hypothyroidism [35], 
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and mouse Tg bearing the C1976S mutation still can follow the secretory pathway, albeit 
with less efficiency (Figure 4-1A, also in [7, 36]). However, secretory II-III bearing the 
C1976S mutation prevents proper disulfide bonding and completely blocks its secretion 
(Figure 4-1B). Therefore, the detrimental effect of local domain-specific misfolding in Tg 
regions I-II-III may be at least partially suppressed in the context of intact Tg (By 
contrast, local misfolding in the ChEL domain has devastating impact on Tg secretion, as 
seen in cog mice or rdw rats [5, 37]). These findings suggest that chaperone function of 
the ChEL domain helps to protect Tg from potential misfolding caused by upstream 
mutations. This clearly speaks to the evolutionary importance of maintaining the ChEL 
domain in full-length Tg. 
 
Future directions 
(1) Molecular dissection to identify interacting site(s) in I-II-III and ChEL 
The oxidative maturation and secretion of Tg regions I-II-III are rescued by 
secretory ChEL, which I believe simulates the intramolecular interaction within intact Tg 
monomers. In support of this view, the same “D” to “E” maturation occurs in both intact 
Tg and regions I-II-III (with ChEL in trans). It appears that regions I-II-III and secretory 
ChEL physically interact specifically since the binding stoichiometry between I-II-III and 
ChEL has been measured by me and is around 1.13 ± 0.27, i.e., the same as when they 
are contiguously connected in intact Tg. Thus, in trans, the interaction between I-II-III 
and ChEL recapitulates the domain interactions within intact Tg. 
What areas in regions I-II-III and ChEL are involved in these interactions? First, 
co-immunoprecipitation between secretory ChEL and each individually-expressed region 
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from I-II-III should be performed to identify the interacting regions. Thus far in 
preliminary experiments, I could not co-immunoprecipitate secretory II-III with ChEL 
(not shown). So I do not believe that ChEL binds in those regions. In addition, as has 
already been mentioned, secretory II-III can be efficiently secreted without help of ChEL, 
and its secretion is not affected by co-expression of secretory ChEL (not shown). These 
findings suggest that region I, or a hinge region between the repeats, is likely to contain 
the binding site most important to the interaction with the ChEL domain. 
For ChEL itself, alanine scanning could be used to identify potential interacting 
site(s), since the ChEL domain’s globular structure may make it very difficult to use 
progressive truncation as an experimental approach. Alternatively, ChEL-
acetylcholinesterase chimeras could be tried, or neuroligin 1 [25] could be used to 
explore which conserved (or unconserved) sequences may be involved in the rescue of 
secretion of I-II-III. 
 
(2) Disulfide maturation of the Tg monomer 
Considering that the repeat units and the ChEL domain are believed to be 
independent folding units, the progression of disulfide maturation seen in the “D” to “E” 
transition by nonreducing SDS-PAGE, which depends on the ChEL domain, is likely to 
occur as a consequence of posttranslational interactions between distinct Tg regions. Tg 
has some cysteine-rich areas with no known homology to other proteins in the database. 
Since fully folded and secreted Tg has no recognizable reaction with alkylating agents 
such as AMS (Figure 2-1) or PEG-maleimide, the cysteines in the non-homologous hinge 
regions are believed to also form intrachain disulfide bonds. Conceivably, disulfide bonds 
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in the non-homologous region could drive the “D” to “E” transition. Sequential mutations 
of these relatively few non-homologous cysteines could be tried in order to identify the 
critical disulfide bonds as analyzed by nonreducing SDS-PAGE. 
In preliminary experiments, a Tg-C1245R mutation in the non-homologous hinge 
region, known to cause mild hypothyroidism [36], appears to be one of the potential 
cysteines to form intrachain disulfide bonds to stabilize the final mature “E” form (Figure 
4-2B). Given that mutagenesis of cysteines in other non-homology areas does not prevent 
the final disulfide maturation (Figure 4-2B), the area after the 10th type 1 repeat, which 
includes C1245R, may contribute to the shift from “D” to “E” as seen by nonreducing 
SDS-PAGE. Besides C1245R, at least one other cysteine in this area may contribute to 
this critical maturation step. Such a view is indeed consistent with the sequence after the 
10th type 1 repeat functioning as a true hinge region in the Tg molecule. It may be of 
interest to mutagenically delete this hinge region, either in full Tg or in I-II-III (in 
presence of ChEL in trans) to determine if this renders Tg refractory to disulfide 
maturation. 
Characterization of I-II-III interactions with ChEL has potential importance for 
understanding Tg homodimerization. I-II-III alone appears to have no intrinsic propensity 
to dimerize, but I-II-III enhances ChEL dimerization (also Tg dimerization). Tg 
dimerization first begins when Tg monomer has matured to the “E” form as seen by 
nonreducing SDS-PAGE. Thus ChEL may help I-II-III fold, which in turn helps ChEL to 
make a more stable homodimer. It has been suggested previously that some area in region 





(3) Further understanding the role of ER oxidoreductases in Tg folding and 
secretion 
Secretory proteins require ER chaperones and oxidoreductases for their proper 
folding and efficient secretion. Disulfide maturation, especially for Tg may be a rate-
limiting step in the process [12]. Considering that Tg shows early covalent interactions 
with ER oxidoreductases [4], it is expected that ER oxidoreductases contribute 
significantly to the disulfide maturation of Tg. Also, ERp29 has been reported to serve as 
an escort for Tg [38, 39], just as an ERp29-homologue in fly, Wind, does for Pipe, a 
glycosaminoglycan-modifying enzyme [40]. 
Knockdown of these ER oxidoreductases using siRNA could be applied to 
understand their role in Tg disulfide maturation and secretion. The nonreducing SDS-
PAGE approach would allow the observation of changes in Tg maturation as a 
consequence of oxidoreductase knockdown. In a preliminary experiment, an siRNA 
against human PDI (designed by G. Rajpal in our laboratory and in Dr. B. Tsai’s 
laboratory) efficiently decreased endogenous PDI in 293 cells (≥ 70% knockdown) and 
this improved wild-type Tg secretion (not shown). Considering that overexpression of 
PDI facilitates the degradation of misfolded Tg [41], PDI may work by preventing 
premature secretion of incompletely folded secretory proteins. This behavior is 
consistently found in BiP [42] and reported for other ER chaperones. 
Molecular dissection of Tg via the expression of discrete regions could give 
further understanding of the role of ERp29. In preliminary experiments, I did not observe 
any interaction between secretory ChEL and ERp29 as judged by co-immnopreciptation, 
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not shown) while I could see interaction between full-length Tg and ERp29 (not shown). 
Does this mean that ERp29 may bind upstream regions of Tg? I suspect that this might be 
the case. As seen in Figure 4-3, inhibition of ERp29 function by overexpression of a 
dominant negative form of ERp29 (NTD ERp29) begins to allow an increased fraction of 
I-II-III to be secreted (asterisk in Figure 4-3). Currently, it is too early to explain the 
nature of the ERp29 interaction with I-II-III and the role in which ERp29 is involved in 
physiological Tg secretion. Co-immunoprecipitation between Tg regions I-II-III and 
ERp29 and studies of disulfide maturation of I-II-III should be further pursued in order to 
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Figure 4-1. Differences in mutational phenotype of C1976S for secretion of Tg and 
secretory II-III. (A) 293 cells were either untransfected (control, [Con]) or transiently 
transfected with wild-type Tg or Tg C1976S. Cells were pulse-labeled with 
35
S-amino 
acids for 20 min and chased for 4 h in complete media. Media were immunoprecipitated 
with anti-Tg before SDS-PAGE and fluorography. Tg C1976S has been reported to secret 
less efficiently than wild-type Tg [7, 36]. (B) 293 cells were either untransfected (control, 
[Con]) or transiently transfected with HA tagged secretory II-III or secretory II-III with 
C1976S mutation (also tagged with HA). Top panel: Cells were pulse-labeled with 
35
S-
amino acids for 30 min and chased for 5 h in complete media. Media were 
immunoprecipitated with anti-HA, then analyzed by SDS-PAGE and fluorography. 
Bottom panel: Media were collected for 24 h and analyzed by SDS-PAGE, electrotransfer, 
and immunoblotting with anti-HA antibody. Note that no detectable secretory II-III with 





Figure 4-2. Intrachain disulfide bond mediating final maturation (“D” to “E”) of Tg. 
(A) Tg structure shown with cysteines. Tg has total 122 cysteine and most of them are 
believed to form intrachain disulfide bonds. Each numbering indicates the number of 
cysteines in subunits, ChEL domain, and also unknown areas. Some of cysteines in such 
unknown areas are expected to form intrachain disulfide bonds and stabilize final native 
structure of Tg. Sequential mutations can be tried to identify such disulfide bonds. The 
mutations tried preliminarily are shown (down arrow). (B) 293 cells were either 
untransfected (control, [Con]) or transiently transfected with wild-type Tg, Tg C1245R, 
Tg C388S, or Tg C345/388S. Cells were pulse-labeled with 
35
S-amino acids for 20 min 
and chased in complete media. Cells and media were immunoprecipitated with anti-Tg 
and treated with PNGase F under nonreducing condition before nonreducing SDS-PAGE 
and fluorography. Tg C1489S has been tried previously and can reach final disulfide 
matured form, “E” (not shown). Note that Tg C1245R shows decreased “E” form which 
was either inhibited to form “E” or could form but not stabilized under SDS-PAGE and 




Figure 4-3. Enhanced secretion of Tg regions I-II-III by suppression of ERp29. 293 
cells were either untransfected (control) or transiently co-transfected with 1µg of plasmid 
encoding Tg regions I-II-III with 2µg of either blank plasmid or plasmid encoding wild-
type ERp29 (WT ERp29) or N-terminal domain of ERp29 with its own ER retention 
signal (NTD ERp29). Cells were pulse-labeled with 
35
S-amino acids for 30 min and 
chased in complete media. Cells (C) and media (M) were immunoprecipitated with anti-
Tg before SDS-PAGE and fluorography. Note that some I-II-III (without ChEL) was 
rescued in secretion (asterisk) under suppression of ERp29 by dominant negative form of 
ERp29 (NTD ERp29), but has no change under overexpression of wild-type ERp29. The 
plasmids encoding wild-type or NTD ERp29 are kindly gift from Dr. Mkrtchian, S. 
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